EurekaMag Full Text Articles Chapter 7,647

Khazaeli, M.B.; Saleh, M.N.; Liu, T.P.; Meredith, R.F.; Wheeler, R.H.; Baker, T.S.; King, D.; Secher, D.; Allen, L.; Et-Al 1991: Pharmacokinetics and immune response of iodine 131 chimeric mouse human b72.3 human gamma 4 monoclonal antibody in humans. Cancer Research 51(20): 5461-5466

O'Neill, P.; Nye, K.; Douce, G.; Andrews, J.; Wise, R. 1990: Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers. Antimicrobial Agents and ChemoTherapy 34(2): 232-234

Uccelli, V.; Deleforge, J.; Boisrame, B. 1988: Pharmacokinetics and local tolerance of two oxytetracycline formulations in the dairy cow. Recueil de Medecine Veterinaire de l'Ecole d'Alfort 164(11): 939-943

Seredenin, S.B.; Khlopushina, T.G.; Zherdev, V.P. 1990: Pharmacokinetics and metabolism of antipyrine in inbred mice. Khimiko-Farmatsevticheskii Zhurnal 24(9): 24-26

Huo, J.Z.; Xia, W.J.; Xue, M.; Zhou, Z.T. 1991: Pharmacokinetics and metabolism of artesunate in cows. Yao Xue Xue Bao 26(3): 225-227

Klemm, V.; Morgenrot, U.; Starke, F.; Zeriatke, V.; Yoran, U. 1990: Pharmacokinetics and metabolism of bonnecor in rats. Farmakologiya i Toksikologiya 53(3): 43-44

Lachmann, G.; Siegemund, B.; Kusche, W. 1990: Pharmacokinetics and metabolism of carbon 14 oxaceprol in beagle dogs after intramuscular and oral administration. Arzneimittel-Forschung 40(2): 200-206

Schuler, U.; Waidelich, P.; Kolb, H.; Wagner, T.; Ehninger, G. 1991: Pharmacokinetics and metabolism of cyclophosphamide administered after total body irradiation of bone marrow transplant recipients. European Journal of Clinical Pharmacology 40(5): 521-523

Tasso, M.J.; Boddy, A.V.; Price, L.; Wyllie, R.A.; Pearson, A.D.; Idle, J.R. 1992: Pharmacokinetics and metabolism of cyclophosphamide in paediatric patients. Cancer Chemotherapy and Pharmacology 30(3): 207-211

Yeung, P.K.; Mosher, S.J.; Pollak, P.T. 1991: Pharmacokinetics and metabolism of diltiazem in rabbits after a single intravenous or single oral administration. European Journal of Drug Metabolism and Pharmacokinetics 16(1): 69-74

Smith, D.A.; Rasmussen, H.S.; Stopher, D.A.; Walker, D.K. 1992: Pharmacokinetics and metabolism of dofetilide in mouse, rat, dog and man. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 22(6): 709-719

Prokopenko, V.M.; Eliseev, V.V.; Krylova, I.B.; Shapot, E.V. 1989: Pharmacokinetics and metabolism of gmp. Khimiko-Farmatsevticheskii Zhurnal 23(9): 1042-1043

Wala, E.P.; Sloan, J.W.; Martin, W.R.; Pruitt, T. 1991: Pharmacokinetics and metabolism of halazepam in naive and dependent dogs. Pharmacology Biochemistry and Behavior 38(3): 561-567

Dubois, J.; Atassi, G.; Hanocq, M.; Abikhalil, F. 1988: Pharmacokinetics and metabolism of hexamethylmelamine in mice bearing renal cell tumors. Cancer Chemotherapy and Pharmacology 22(4): 282-288

Kellner, H.M.; Volz, M.; Badder, E.; Kürzel, G.U.; Eckert, H.G. 1991: Pharmacokinetics and metabolism of HOE 077. Preclinical studies. Journal of Hepatology 13(Suppl 3): S48

Stuck, A.E.; Frey, F.J.; Heizmann, P.; Brandt, R.; Weidekamm, E. 1989: Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis. Antimicrobial Agents and ChemoTherapy 33(3): 373-381

Mross, K.; Mayer, U.; Hamm, K.; Burk, K.; Hossfeld, D.K. 1990: Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans. European Journal of Clinical Pharmacology 39(5): 507-513

Utaaker, E.; Lundgren, S.; Kvinnsland, S.; Aakvaag, A. 1988: Pharmacokinetics and metabolism of medroxyprogesterone acetate in patients with advanced breast cancer. Journal of Steroid Biochemistry 31(4a): 437-441

Pedersen, J.H.; Andersen, H.O.; Olsen, P.S.; Henriksen, J.H. 1989: Pharmacokinetics and metabolism of neurotensin in man. Journal of Clinical Endocrinology and Metabolism 68(2): 294-300

Camus, P.; Coudert, B.; D'Athis, P.; Foucher, P.; Delchambre, J.; Dupront, A.; Jeannin, L. 1991: Pharmacokinetics and metabolism of nilutamide in the isolated rat lung. Journal of Pharmacology and Experimental Therapeutics 259(3): 1247-1255

Cova, D.; De Angelis, L.; Giavarini, F.; Palladini, G.; Perego, R. 1992: Pharmacokinetics and metabolism of oral diosmin in healthy volunteers. International Journal of Clinical Pharmacology Therapy and Toxicology 30(1): 29-33

Hoffman, H.E.; Gaylord, J.C.; Blasecki, J.W.; Shalaby, L.M.; Whitney, C.C. 1988: Pharmacokinetics and metabolism of rimantadine hydrochloride in mice and dogs. Antimicrobial Agents and ChemoTherapy 32(11): 1699-1704

Ol'shanskaya O.V.; Pol'shakov V.I.; Presnova, Z.F.; Chernov, V.A.; Safonova, T.S.; Shteinpress, A.B. 1988: Pharmacokinetics and metabolism of spirobromine administered orally. Khimiko-Farmatsevticheskii Zhurnal 22(8): 905-907

Barron, M.G.; Hansen, S.C.; Ball, T. 1991: Pharmacokinetics and metabolism of triclopyr in the crayfish (Procambarus clarki). Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(1): 163-167

Marino, A.; Pisanti, N. 1989: Pharmacokinetics and nephrotoxicity of aminoglycoside antibiotics. La Clinica Terapeutica 129(6): 421-428

Vathsala, A.; Woo, K.T.; Lim, C.H. 1991: Pharmacokinetics and nephrotoxicity of cyclosporine. Annals of the Academy of Medicine Singapore 20(4): 507-512

Vandenbrom, R.H.; Wierda, J.M.; Agoston, S. 1990: Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function. Clinical Pharmacokinetics 19(3): 230-240

Obach, R.; Torrent, J.; Colom, H.; Pruñonosa, J.; Peraire, C.; Domenech, J. 1991: Pharmacokinetics and oral bioavailability of carbimide in man. Biopharmaceutics and Drug Disposition 12(6): 425-434

Putcha, L.; Cintrón, N.M.; Tsui, J.; Vanderploeg, J.M.; Kramer, W.G. 1989: Pharmacokinetics and oral bioavailability of scopolamine in normal subjects. Pharmaceutical Research 6(6): 481-485

Cuber, J.C.; Bernard, C.; Gibard, T.; Chayvialle, J.A. 1989: Pharmacokinetics and organ catabolism of cholecystokinin octapeptide in pigs. Regulatory Peptides 26(3): 203-213

Abdalla, A.; Rulin, V.A.; Mazur, N.A.; Chikovani, S.I. 1988: Pharmacokinetics and pharmacodynamics of a new antiarrhythmic drug allapinine. Farmakologiya i Toksikologiya 51(5): 47-49

Drewe, J.; Meier, R.; Timonen, U.; Thumshirn, M.; Munzer, J.; Kissel, T.; Gyr, K. 1991: Pharmacokinetics and pharmacodynamics of a new transdermal delivery system for bopindolol. British Journal of Clinical Pharmacology 31(6): 671-676

Bompadre, S.; Bedetta, C.; Capone, P.; Cingolani, M.L.; Ferrante, L.; Leone, L.; Ripa, S. 1991: Pharmacokinetics and pharmacodynamics of amlodipine in comparison with nifedipine ar in patients with mild to moderate hypertension. Current Therapeutic Research 49(5): 832-842

Kuwajima, I.; Kuramoto, K. 1989: Pharmacokinetics and pharmacodynamics of antihypertensive drugs in the elderly. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 26(2): 131-136

Fisher, D.M.; Canfell, P.C.; Spellman, M.J.; Miller, R.D. 1990: Pharmacokinetics and pharmacodynamics of atracurium in infants and children. Anesthesiology 73(1): 33-37

Kitts, J.B.; Fisher, D.M.; Canfell, P.C.; Spellman, M.J.; Caldwell, J.E.; Heier, T.; Fahey, M.R.; Miller, R.D. 1990: Pharmacokinetics and pharmacodynamics of atracurium in the elderly. Anesthesiology 72(2): 272-275

Donati, F.; Gill, S.S.; Bevan, D.R.; Ducharme, J.; Theoret, Y.; Varin, F. 1991: Pharmacokinetics and pharmacodynamics of atracurium with and without previous suxamethonium administration. British Journal of Anaesthesia 66(5): 557-561

Brier, M.E.; Harding, G.B. 1989: Pharmacokinetics and pharmacodynamics of atrial natriuretic peptide after bolus and infusion administration in the isolated perfused rat kidney. Journal of Pharmacology and Experimental Therapeutics 249(2): 372-377

Shionoiri, H.; Ueda, S.; Minamisawa, K.; Minamisawa, M.; Takasaki, I.; Sugimoto, K.; Gotoh, E.; Ishii, M. 1992: Pharmacokinetics and pharmacodynamics of benazepril in hypertensive patients with normal and impaired renal function. Journal of Cardiovascular Pharmacology 20(3): 348-357

Hildebrand, M.; Staks, T.; Nieuweboer, B. 1990: Pharmacokinetics and pharmacodynamics of cicaprost in healthy volunteers after oral administration of 5 to 20 mug. European Journal of Clinical Pharmacology 39(2): 149-154

Kamilli, I.; Gresser, U.; Zöllner, N. 1991: Pharmacokinetics and pharmacodynamics of different doses of Irtemazole in repeated application. Zeitschrift für Rheumatologie 50(1): 23-28

Cook, D.R.; Freeman, J.A.; Lai, A.A.; Robertson, K.A.; Kang, Y.; Stiller, R.L.; Aggarwal, S.; Abou-Donia, M.M.; Welch, R.M. 1991: Pharmacokinetics and pharmacodynamics of doxacurium in normal patients and in those with hepatic or renal failure. Anesthesia and Analgesia 72(2): 145-150

Dresner, D.L.; Basta, S.J.; Ali, H.H.; Schwartz, A.F.; Embree, P.B.; Wargin, W.A.; Lai, A.A.; Brady, K.A.; Savarese, J.J. 1990: Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesia. Anesthesia and Analgesia 71(5): 498-502

Matteo, R.S.; Young, W.L.; Ornstein, E.; Schwartz, A.E.; Silverberg, P.A.; Diaz, J. 1990: Pharmacokinetics and pharmacodynamics of edrophonium in elderly surgical patients. Anesthesia and Analgesia 71(4): 334-339

Huang R H.; Cha Y M.; Xu X. 1989: Pharmacokinetics and pharmacodynamics of flecainide. Zhongguo Yaolixue Yu Dulixue Zazhi 3(4): 271-276

Rolzhäuser, H.P.; Oestreich, W.; Seiler, K.U.; Peters, T.; Platt, D.; Jorisch, D. 1991: Pharmacokinetics and pharmacodynamics of flunarizine in multimorbid, geriatric patients with vertigo. Arzneimittel-Forschung 41(2): 109-114

Lee, F.W.; Salmonson, T.; Metzler, C.H.; Benet, L.Z. 1990: Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs. Journal of Pharmacology and Experimental Therapeutics 255(3): 1222-1229

Kandrotas, R.J.; Gal, P.; Douglas, J.B.; Deterding, J. 1990: Pharmacokinetics and pharmacodynamics of heparin during hemodialysis: interpatient and intrapatient variability. PharmacoTherapy 10(5): 349-355

Park C W.; Shin S G.; Shin J G.; Jang I J.; Han S H.; Chung H H.; Cha I J. 1990: Pharmacokinetics and pharmacodynamics of intravenous diltiazem in dogs. Seoul Journal of Medicine 31(1): 1-10

Etienne, M.C.; Milano, G.; Frenay, M.; Renee, N.; Francois, E.; Thyss, A.; Schneider, M.; Namer, M. 1992: Pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate in advanced breast cancer patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 10(7): 1176-1182

Karbwang, J.; Bangchang, K.N.; Bunnag, D.; Harinasuta, T. 1991: Pharmacokinetics and pharmacodynamics of mefloquine in Thai patients with acute falciparum malaria. Bulletin of the World Health Organization 69(2): 207-212

Lynn, A.M.; McRorie, T.I.; Slattery, J.T.; Calkins, D.; Opheim, K.E. 1991: Pharmacokinetics and pharmacodynamics of morphine in infant monkeys. Developmental Pharmacology and Therapeutics 16(1): 41-47

Johnson, C.E.; Beekman, R.H.; Kostyshak, D.A.; Nguyen, T.; Oh, D.M.; Amidon, G.L. 1991: Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension. Pediatric Research 29(5): 500-503

Nugent, C.E.; Hill, M.; Hursey, T.; Abramson, F.P. 1991: Pharmacokinetics and pharmacodynamics of nifedipine in pregnant sheep. Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(4): 754-757

Sandborn, W.J.; Forland, S.C.; Cutler, R.E.; Strong, R.M. 1990: Pharmacokinetics and pharmacodynamics of oral and intravenous cimetidine in seriously ill patients. Journal of Clinical Pharmacology 30(6): 568-571

Sonne, J.; Boesgaard, S.; Poulsen, H.E.; Loft, S.; Hansen, J.M.; Døssing, M.; Andreasen, F. 1990: Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism. British Journal of Clinical Pharmacology 30(5): 737-742

Stemler, F.W.; Tezak-Reid, T.M.; McCluskey, M.P.; Kaminskis, A.; Corcoran, K.D.; Shih, M.L.; Stewart, J.R.; Wade, J.V.; Hayward, I.J. 1991: Pharmacokinetics and pharmacodynamics of oximes in unanesthetized pigs. Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology 16(3): 548-558

Somani, S.M. 1989: Pharmacokinetics and pharmacodynamics of physostigmine in the rat after oral administration. Biopharmaceutics and Drug Disposition 10(2): 187-203

Ornstein, E.; Matteo, R.S.; Schwartz, A.E.; Jamdar, S.C.; Diaz, J. 1992: Pharmacokinetics and pharmacodynamics of pipecuronium bromide (Arduan) in elderly surgical patients. Anesthesia and Analgesia 74(6): 841-844

Barth, J.; Damoiseaux, M.; Möllmann, H.; Brandis, K.H.; Hochhaus, G.; Derendorf, H. 1992: Pharmacokinetics and pharmacodynamics of prednisolone after intravenous and oral administration. International Journal of Clinical Pharmacology Therapy and Toxicology 30(9): 317-324

Nichols, A.I.; D'Ambrosio, R.; Pyszczynski, N.A.; Jusko, W.J. 1989: Pharmacokinetics and pharmacodynamics of prednisolone in obese rats. Journal of Pharmacology and Experimental Therapeutics 250(3): 963-970

Caritis, S.N.; Venkataramanan, R.; Cotroneo, M.; Smith, M.; Chiao, J.P.; Habucky, K. 1990: Pharmacokinetics and pharmacodynamics of ritodrine after intramuscular administration to pregnant women. American Journal of Obstetrics and Gynecology 162(5): 1215-1219

Lui, S.F.; Chung, W.W.; Leung, C.B.; Chan, K.; Lai, K.N. 1990: Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Clinical Nephrology 33(1): 47-51

Simons, K.J.; Martin, T.J.; Watson, W.T.; Simons, F.E. 1990: Pharmacokinetics and pharmacodynamics of terfenadine and chlorpheniramine in the elderly. Journal of Allergy and Clinical Immunology 85(3): 540-547

Lapka, R.; Krejci, P.; Lidický, J.; Frühaufová, M.; Rezábek, K. 1989: Pharmacokinetics and pharmacodynamics of terguride following intramuscular administration in cows and goats. Acta Physiologica Polonica 40(1): 139-144

Handelsman, D.J.; Conway, A.J.; Boylan, L.M. 1990: Pharmacokinetics and pharmacodynamics of testosterone pellets in man. Journal of Clinical Endocrinology and Metabolism 71(1): 216-222

Kaiser, G.; Ackermann, R.; Dieterle, W.; Durnin, C.J.; Mcewen, J.; Ghose, K.; Richens, A.; Holmes, I.B. 1990: Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly. European Journal of Clinical Pharmacology 38(4): 379-385

Carver, P.L.; Nightingale, C.H.; Quintiliani, R. 1989: Pharmacokinetics and pharmacodynamics of total and unbound cefoxitin and cefotetan in healthy volunteers. Journal of Antimicrobial ChemoTherapy 23(1): 99-106

Shaheen, O.; Zmeili, S.; al-Qussuois, Y.; Arafat, T.; Mouti, H. 1991: Pharmacokinetics and pharmacodynamics of two commercial oral nifedipine products. International Journal of Clinical Pharmacology Therapy and Toxicology 29(9): 337-341

Schwartz, A.E.; Matteo, R.S.; Ornstein, E.; Halevy, J.D.; Diaz, J. 1992: Pharmacokinetics and pharmacodynamics of vecuronium in the obese surgical patient. Anesthesia and Analgesia 74(4): 515-518

John, D.N.; Fort, S.; Lewis, M.J.; Luscombe, D.K. 1992: Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers. British Journal of Clinical Pharmacology 33(6): 623-627

Wulf, H.; Winckler, K.; Maier, C.; Heinzow, B. 1988: Pharmacokinetics and protein binding of bupivacaine in postoperative epidural analgesia. Acta Anaesthesiologica Scandinavica 32(7): 530-534

Sica, D.A.; Comstock, T.J.; Davis, J.; Manning, L.; Powell, R.; Melikian, A.; Wright, G. 1990: Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals. European Journal of Clinical Pharmacology 39(2): 193-194

Servin, F.; Desmonts, J.M.; Haberer, J.P.; Cockshott, I.D.; Plummer, G.F.; Farinotti, R. 1988: Pharmacokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiology 69(6): 887-891

Möllmann, H.; Barth, J.; Möllmann, C.; Tunn, S.; Krieg, M.; Derendorf, H. 1991: Pharmacokinetics and rectal bioavailability of hydrocortisone acetate. Journal of Pharmaceutical Sciences 80(9): 835-836

Diao, Y.; Li, L.; Zhou, G.H.; Cheng, Y. 1992: Pharmacokinetics and relative bioavailability of ofloxacin tablets in 12 healthy volunteers. Zhongguo Yao Li Xue Bao 13(2): 110-112

Breuel, H.P.; Weimann, H.J.; Dahmen, W.; Hausleiter, H.J.; Bondy, S. 1991: Pharmacokinetics and relative bioavailability of prajmalium bitartrate after single oral dosing. Arzneimittel-Forschung 41(12): 1222-1225

Morin, J.P.; Boutelet, I.; Toutain, H.; Fillastre, J.P. 1988: Pharmacokinetics and renal accumulation of three iodinated contrast agents. A comparative study of Telebrix, Hexabrix and Omnipaque in the rabbit. Drugs under Experimental and Clinical Research 14(11): 679-686

Shah, B.H.; Mawaz, M.; Javed, I.; Gilani A U H. 1989: Pharmacokinetics and renal excretion of sulfamethoxazole in sheep. Archives of Pharmacal Research 12(3): 154-159

Cuzzolin, L.; Fanos, V.; Zambreri, D.; Padovani, E.M.; Benoni, G. 1991: Pharmacokinetics and renal tolerance of aztreonam in premature infants. Antimicrobial Agents and ChemoTherapy 35(9): 1726-1728

Leppik, I.E.; Boucher, B.A.; Wilder, B.J.; Murthy, V.S.; Watridge, C.; Graves, N.M.; Rangel, R.J.; Rask, C.A.; Turlapaty, P. 1990: Pharmacokinetics and safety of a phenytoin prodrug given i.v. or i.m. in patients. Neurology 40(3 Pt 1): 456-460

Broggini, M.; Botta, V.; Fonio, W.; Mornatti, R.; Parini, J. 1990: Pharmacokinetics and safety of flomoxef after a single intramuscular dose in healthy volunteers. Archivio di Medicina Interna 42(1): 61-72

Hunt, T.L.; Adams, M.A. 1989: Pharmacokinetics and safety of lomefloxacin following multiple doses. Diagnostic Microbiology and Infectious Disease 12(2): 181-187

Nahata, M.C.; Ford, C.; Ruymann, F.B. 1992: Pharmacokinetics and safety of prochlorperazine in paediatric patients receiving cancer chemotherapy. Journal of Clinical Pharmacy and Therapeutics 17(2): 121-123

Morse, I.S. 1990: Pharmacokinetics and safety of single oral doses of lomefloxacin. Biopharmaceutics and Drug Disposition 11(6): 543-551

Marchbanks, C.R.; Dudley, M.N.; Flor, S.; Beals, B. 1992: Pharmacokinetics and safety of single rising doses of ofloxacin in healthy volunteers. PharmacoTherapy 12(1): 45-49

Patel, B.A.; Chu, C.K.; Boudinot, F.D. 1989: Pharmacokinetics and saturable renal tubular secretion of zidovudine in rats. Journal of Pharmaceutical Sciences 78(7): 530-534

Boeckh, M.; Lode, H.; Deppermann, K.M.; Grineisen, S.; Shokry, F.; Held, R.; Wernicke, K.; Koeppe, P.; Wagner, J.; Krasemann, C. 1990: Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole. Antimicrobial Agents and ChemoTherapy 34(12): 2407-2414

Mckellar, Q.A.; Galbraith, E.A.; Simmons, R.D. 1991: Pharmacokinetics and serum thromboxane inhibition of two nsaids when administered to dogs by the intravenous or subcutaneous route. Journal of Small Animal Practice 32(7): 335-340

Tanaka, Y.; Hashimoto, S.; Natsuyama, T. 1991: Pharmacokinetics and solute movement in the tissue. Journal of Kyoto Prefectural University of Medicine 100(9): 855-863

Adams, W.J.; McGovren, J.P.; Dalm, E.A.; Brewer, J.E.; Hosley, J.D. 1989: Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey. Cancer Research 49(22): 6328-6336

Endo, M.; Ogawa, R.; Nishimura, N. 1989: Pharmacokinetics and the lung uptake of lidocaine during epidural anesthesia. Masui. Japanese Journal of Anesthesiology 38(1): 59-65

Larsen, F.G.; Nielsen-Kudsk, F.; Jakobsen, P.; Weismann, K.; Kragballe, K. 1992: Pharmacokinetics and therapeutic efficacy of retinoids in skin diseases. Clinical Pharmacokinetics 23(1): 42-61

Hou C Q.; Wang Q N. 1989: Pharmacokinetics and tissue concentration of ceftazidime in dogs. Zhongguo Kanfshengsu Zazhi 14(4): 262-266

L.X.T.; Wang Q N.; Sheng J Q. 1989: Pharmacokinetics and tissue concentration of ceftizoxime in dogs. Zhongguo Kanfshengsu Zazhi 14(2): 119-125

Huang W X.; Wang Q N. 1990: Pharmacokinetics and tissue concentration of temocillin in dogs. Zhongguo Kanfshengsu Zazhi 15(4): 275-280

Nahata, M.C.; Durrell, D.E.; Ginn-Pease, M.E.; King, D.R. 1991: Pharmacokinetics and tissue concentrations of cefazolin in pediatric patients undergoing gastrointestinal surgery. European Journal of Drug Metabolism and Pharmacokinetics 16(1): 49-52

Walstad, R.A.; Aanderud, L.; Thurmann-Nielsen, E. 1988: Pharmacokinetics and tissue concentrations of ceftazidime in burn patients. European Journal of Clinical Pharmacology 35(5): 543-549

Martin, J.F.; Plakas, S.M.; Holley, J.H.; Kitzman, J.V.; Guarino, A.M. 1990: Pharmacokinetics and tissue disposition of the off flavor compound 2 methylisoborneol in the channel catfish ictalurus punctatus. Canadian Journal of Fisheries and Aquatic Sciences 47(3): 544-547

Fraschini, F.; Scaglione, F.; Falchi, M.; Dugnani, S.; Mezzetti, M.; Cicchetti, F.; Alfano, G.; Pintucci, G.P. 1990: Pharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in man. Journal of ChemoTherapy 2(3): 171-177

Gabizon, A.; Shiota, R.; Papahadjopoulos, D. 1989: Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. Journal of the National Cancer Institute 81(19): 1484-1488

Gascon, M.P.; Porchet, H.C.; Le Cotonnec, J.Y.; Ythier, A.; Wallach, D.; Piguet, P.F.; Grau, G.E. 1992: Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in mice. Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(4): 592-595

Colas Linhart, N.; Laforest, M.D.; Guiraud Vitaux, F.; Gardin, I.; Petiet, A.; Berthelot, J.L.; Bok, B. 1990: Pharmacokinetics and tissue distribution of technetium 99m labelled enoxaparin in the rat evaluation of dosimetry parameters. Biomedicine and Pharmacotherapy 44(6): 317-324

Cumin, F.; Schnell, C.; Richert, P.; Raschdorf, F.; Probst, A.; Schmid, K.; Wood, J.M.; de Gasparo, M. 1990: Pharmacokinetics and tissue distribution of the renin inhibitor N-(2-(R)-benzyl-3-tert-butyl-sulfonyl-propionyl)-His-ChacVal-n-butylami ne in marmosets. Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(6): 831-835

Martin, C.; Bruguerolle, B.; Mallet, M.N.; Condomines, M.; Sastre, B.; Gouin, F. 1990: Pharmacokinetics and tissue penetration of a single dose of ornidazole (1,000 milligrams intravenously) for antibiotic prophylaxis in colorectal surgery. Antimicrobial Agents and ChemoTherapy 34(10): 1921-1924

Wise, R.; O'Sullivan, N.; Johnson, J.; Andrews, J.M. 1992: Pharmacokinetics and tissue penetration of ampicillin and brobactam following oral administration of 2085P. Antimicrobial Agents and ChemoTherapy 36(5): 1002-1004

Nye, K.J.; Shi, Y.G.; Andrews, J.M.; Wise, R. 1989: Pharmacokinetics and tissue penetration of cefepime. Journal of Antimicrobial ChemoTherapy 24(1): 23-28

Kavi, J.; Andrews, J.M.; Ashby, J.P.; Hillman, G.; Wise, R. 1988: Pharmacokinetics and tissue penetration of cefpirome, a new cephalosporin. Journal of Antimicrobial ChemoTherapy 22(6): 911-916

Nye, K.; O'Neill, P.; Andrews, J.M.; Wise, R. 1990: Pharmacokinetics and tissue penetration of cefprozil. Journal of Antimicrobial ChemoTherapy 25(5): 831-835

Wise, R.; Nye, K.; O'Neill, P.; Wostenholme, M.; Andrews, J.M. 1990: Pharmacokinetics and tissue penetration of ceftibuten. Antimicrobial Agents and ChemoTherapy 34(6): 1053-1055

Stone, J.W.; Andrews, J.M.; Ashby, J.P.; Griggs, D.; Wise, R. 1988: Pharmacokinetics and tissue penetration of orally administered lomefloxacin. Antimicrobial Agents and ChemoTherapy 32(10): 1508-1510

Wise, R.; Johnson, J.; O'Sullivan, N.; Andrews, J.M.; Imbimbo, B.P. 1991: Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent. Journal of Antimicrobial ChemoTherapy 28(6): 905-909

Lee, J.W.; Lin, C.; Loebenberg, D.; Rubin, M.; Pizzo, P.A.; Walsh, T.J. 1989: Pharmacokinetics and tissue penetration of Sch 39304 in granulocytopenic and nongranulocytopenic rabbits. Antimicrobial Agents and ChemoTherapy 33(11): 1932-1935

Wise, R.; Logan, M.; Cooper, M.; Andrews, J.M. 1991: Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin. Antimicrobial Agents and Chemotherapy 35(6): 1081-1084

Kinzig, M.; Sörgel, F.; Brismar, B.; Nord, C.E. 1992: Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery. Antimicrobial Agents and ChemoTherapy 36(9): 1997-2004

Del Favero, A.; Patoia, L.; Rosina, R.; Buniva, G.; Danese, A.; Bernareggi, A.; Molini, E.; Cavenaghi, L. 1991: Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses. Antimicrobial Agents and ChemoTherapy 35(12): 2551-2557

Morrison, P.J.; Mant, T.G.; Norman, G.T.; Robinson, J.; Kunka, R.L. 1988: Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses. Antimicrobial Agents and ChemoTherapy 32(10): 1503-1507

Setnikar, I.; Chisté, R.; Giacovelli, G.; Rovati, L.C. 1989: Pharmacokinetics and tolerance of repeated oral doses of loxiglumide. Arzneimittel-Forschung 39(11): 1454-1459

Williams, P.E.; Muirhead, G.J.; Worth, E.; Zimmer, R.; Lücker, P. 1990: Pharmacokinetics and tolerance of romazarit after oral administration of ascending single doses to healthy human volunteers. European Journal of Drug Metabolism and Pharmacokinetics 15(4): 317-322

Ferner, R.E.; Odemuyiwa, O.; Field, A.B.; Walker, S.; Volans, G.N.; Bateman, D.N. 1989: Pharmacokinetics and toxic effects of diltiazem in massive overdose. Human Toxicology 8(6): 497-499

Paar, W.D.; Von Bergmann, K. 1992: Pharmacokinetics and toxicity of bismuth compound. Verdauungskrankheiten 10(4): 140-143

Johnson, P.J.; Kalayci, C.; Dobbs, N.; Raby, N.; Metivier, E.M.; Summers, L.; Harper, P.; Williams, R. 1991: Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol. Journal of Hepatology 13(1): 120-127

Baciewicz, F.A.; Arredondo, M.; Chaudhuri, B.; Crist, K.A.; Basilius, D.; Bandyopadhyah, S.; Thomford, N.R.; Chaudhuri, P.K. 1991: Pharmacokinetics and toxicity of isolated perfusion of lung with doxorubicin. Journal of Surgical Research 50(2): 124-128

Tjuljandin, S.A.; Doig, R.G.; Sobol, M.M.; Watson, D.M.; Sheridan, W.P.; Morstyn, G.; Mihaly, G.; Green, M.D. 1990: Pharmacokinetics and toxicity of two schedules of high dose epirubicin. Cancer Research 50(16): 5095-5101

Sileni, V.C.; Fosser, V.; Maggian, P.; Padula, E.; Beltrame, M.; Nicolini, M.; Arslan, P. 1992: Pharmacokinetics and tumor concentration of intraarterial and intravenous cisplatin in patients with head and neck squamous cancer. Cancer Chemotherapy and Pharmacology 30(3): 221-225

Kantelip, J.P.; Aiache, J.M.; Beyssac, E.; Abella, M.L. 1991: Pharmacokinetics and urinary electrolyte excretion effects of oral frusemide and frusemide amiloride combination tablets in healthy subjects. Therapie (London/Paris) 46(6): 475-479

Garg, S.K.; Verma, S.P.; Garg, B.D. 1991: Pharmacokinetics and urinary excretion of gentamicin in Bubalus bubalis calves following intramuscular administration. Research in Veterinary Science 50(1): 102-105

Kleinow, K.M.; Beilfuss, W.L.; Jarboe, H.H.; Droy, B.F.; Lech, J.J. 1992: Pharmacokinetics bioavailability distribution and metabolism of sulfadimethoxine in the rainbow trout oncorhynchus mykiss. Canadian Journal of Fisheries and Aquatic Sciences 49(5): 1070-1077

Mikus, G.; Mast, V.; Fischer, C.; Machleidt, C.; Kuhlmann, U.; Eichelbaum, M. 1991: Pharmacokinetics, bioavailability, metabolism and acute and chronic antihypertensive effects of nitrendipine in patients with chronic renal failure and moderate to severe hypertension. British Journal of Clinical Pharmacology 31(3): 313-322

Achtert, G.; Scherrmann, J.M.; Christen, M.O. 1989: Pharmacokinetics/bioavailability of colchicine in healthy male volunteers. European Journal of Drug Metabolism and Pharmacokinetics 14(4): 317-322

Srivastava, A.K.; Malik, J.K. 1989: Pharmacokinetics biochemical effects and dosage regimen of pralidoxime in buffaloes. Indian Journal of Animal Sciences 59(12): 1498-1500

Watkinson, J.C.; Allen, S.; Lazarus, C.R.; Sinclair, J.; Blake, G.M.; Clarke, S.E.M. 1990: Pharmacokinetics biodistribution and dosimetry of technetium 99m v dmsa in humans with squamous cell carcinoma. Nuclear Medicine Communications 11(5): 343-360

Agrawal, S.; Temsamani, J.; Tang, J.Y. 1991: Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proceedings of the National Academy of Sciences of the United States of America 88(17): 7595-7599

Garrigou-Gadenne, D.; Burke, J.T.; Durand, A.; Depoortere, H.; Thénot, J.P.; Morselli, P.L. 1989: Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat. Journal of Pharmacology and Experimental Therapeutics 248(3): 1283-1288

Nahata, M.C.; Fan-Havard, P.; Barson, W.J.; Bartkowski, H.M.; Kosnik, E.J. 1990: Pharmacokinetics, cerebrospinal fluid concentration, and safety of intravenous rifampin in pediatric patients undergoing shunt placements. European Journal of Clinical Pharmacology 38(5): 515-517

Srivastava, A.K.; Khanikor, H.N.; Malik, J.K. 1988: Pharmacokinetics dosage regimen and biochemical effects of 2 3 butanedione monoxime in sheep. Pakistan Journal of Agricultural Research 9(4): 585-590

Lipworth, B.J.; Clark, R.A.; Dhillon, D.P.; Moreland, T.A.; Struthers, A.D.; Clark, G.A.; Mcdevitt, D.G. 1989: Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. European Journal of Clinical Pharmacology 37(6): 567-571

Toutain, P.L.; Oukessou, M. 1990: Pharmacokinetics elements of methodology. Recueil de Medecine Veterinaire de l'Ecole d'Alfort 166(3): 195-203

Mazzei, T.; Mini, E.; Eandi, M.; Reali, E.F.; Fioretto, L.; Bartoletti, R.; Rizzo, M.; Calabrò, G.; Periti, P. 1989: Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation. Drugs under Experimental and Clinical Research 15(8): 373-387

Chandraprakash, K.S.; Udupa, N.; Umadevi, P.; Pillai, G.K. 1990: Pharmacokinetics evaluation of surfactant vesicle entrapped methotrexate in tumor bearing mice. International Journal of Pharmaceutics 61(1-2): R1-R3

Kuo, B.S.; Kusmik, W.F.; Poole, J.C.; Elsea, S.H.; Chang, J.; Hwang, K.K. 1992: Pharmacokinetic evaluation of two human epidermal growth factors (hEGF51 and hEGF53) in rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(1): 23-30

Bogen, K.T. 1988: Pharmacokinetics for regulatory risk analysis: the case of trichloroethylene. Regulatory Toxicology and Pharmacology: Rtp 8(4): 447-466

van Rossum, J.M.; de Bie, J.E.; van Lingen, G.; Teeuwen, H.W. 1989: Pharmacokinetics from a dynamical systems point of view. Journal of Pharmacokinetics and Biopharmaceutics 17(3): 365-92; discussion 393-400

Moe, G.W.; Forster, C.; de Bold, A.J.; Armstrong, P.W. 1990: Pharmacokinetics, hemodynamic, renal, and neurohormonal effects of atrial natriuretic factor in experimental heart failure. Clinical and Investigative Medicine 13(3): 111-118

Doignon, J.L.; Grognet, J.M.; Thebault, J.J.; Caplain, M.; Capron, M.H.; Pelletier, B.; Wehrlen, M.; Istin, M. 1990: Pharmacokinetics in healthy subjects of two oral dosages of altizide and spironolactone. Therapie (London/Paris) 45(6): 475-481

Koeppe, P.; Hoeffler, D.; Mattiucci, M.; Kienle, E. 1989: Pharmacokinetics in healthy volunteers and patients with impaired renal function after oral cefotiam hexetil. Acta Therapeutica 15(4): 337-354

Wawrzynczak, E.J.; Cumber, A.J.; Henry, R.V.; May, J.; Newell, D.R.; Parnell, G.D.; Worrell, N.R.; Forrester, J.A. 1990: Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin. Cancer Research 50(23): 7519-7526

Kanekal, S.; Fraiser, L.; Kehrer, J.P. 1992: Pharmacokinetics, metabolic activation, and lung toxicity of cyclophosphamide in C57/B16 and ICR mice. Toxicology and Applied Pharmacology 114(1): 1-8

Mevius, D.J.; Breukink, H.J.; Guelen, P.J.; Jansen, T.; De Grève, B. 1990: Pharmacokinetics, metabolism and renal clearance of flumequine in veal calves. Journal of Veterinary Pharmacology and Therapeutics 13(2): 159-169

Segredo, V.; Shin, Y.S.; Sharma, M.L.; Gruenke, L.D.; Caldwell, J.E.; Khuenl-Brady, K.S.; Agoston, S.; Miller, R.D. 1991: Pharmacokinetics, neuromuscular effects, and biodisposition of 3-desacetylvecuronium (Org 7268) in cats. Anesthesiology 74(6): 1052-1059

Timmer, C.J.; Apter, D.; Voortman, G. 1990: Pharmacokinetics of 3-keto-desogestrel and ethinylestradiol released from different types of contraceptive vaginal rings. Contraception 42(6): 629-642

Sugihara, K.; Morino, A.; Sugiyama, M.; IIda, S.; Nomura, A. 1990: Pharmacokinetics of 4-acetylaminophenylacetic acid. 2nd communication: tissue accumulation and enzyme induction in rats after repeated administration, and placental and milk transfer after single dosing. Arzneimittel-Forschung 40(7): 806-810

Kozlov, S.T.; Bumazhnyi, B.E.; Kholodov, L.E.; Kuznetsova, L.V.; Knizhnik, A.Z. 1988: Pharmacokinetics of 4 amino 5 6 tetramethylene 1h 2 3 dihydropyridine in rats. Khimiko-Farmatsevticheskii Zhurnal 22(7): 787-789

Eksborg, S.; Stendahl, U.; Antila, K. 1989: Pharmacokinetics of 4' epi-adriamycin after morning and afternoon intravenous administration. Medical Oncology and Tumor PharmacoTherapy 6(3): 195-197

Chung, S.M.; Yoon, E.J.; Kim, S.H.; Lee, M.G.; Lee, H.; Park, M.K.; Kim C K. 1991: Pharmacokinetics of 5 fluorouracil after intravenous infusion of 5 fluorouracil acetic acid human serum albumin conjugates to rabbits. International Journal of Pharmaceutics 68(1-3): 61-68

Czejka, M.; Schueller, J.; Fogl, U. 1992: Pharmacokinetics of 5 fluorouracil after iv administration with regard to the erythrocytes. Archiv der Pharmazie (Weinheim) 325(2): 73-75

Chelluri, L.; Warren, J.; Jastremski, M.S. 1989: Pharmacokinetics of a 3 mg/kg body weight loading dose of gentamicin or tobramycin in critically ill patients. Chest 95(6): 1295-1297

Strocchi, E.; Ambrosioni, E.; Palazzini, E.; Galli, G. 1991: Pharmacokinetics of a controlled release preparation of naproxen. International Journal of Clinical Pharmacology Therapy and Toxicology 29(7): 253-256

Goudable, C.; Saivin, S.; Houin, G.; Sie, P.; Boneu, B.; Tonthat, H.; Suc, J.M. 1991: Pharmacokinetics of a low molecular weight heparin (Fraxiparine) in various stages of chronic renal failure. Nephron 59(4): 543-545

Pedersen, P.C.; Ostergaard, P.B.; Hedner, U.; Bergqvist, D.; Mätzsch, T. 1991: Pharmacokinetics of a low molecular weight heparin, logiparin, after intravenous and subcutaneous administration to healthy volunteers. Thrombosis Research 61(5-6): 477-487

Boré, P.; Rahmani, R.; van Cantfort, J.; Focan, C.; Cano, J.P. 1989: Pharmacokinetics of a new anticancer drug, navelbine, in patients. Comparative study of radioimmunologic and radioactive determination methods. Cancer ChemoTherapy and Pharmacology 23(4): 247-251

Jiang H.; Deng Z.; He G. 1990: Pharmacokinetics of a new rodenticide demethylbromethalin. Acta Theriologica Sinica 10(3): 227-230

Russell, W.J.; Badcock, N.R.; Frewin, D.B.; Sansom, L.N. 1988: Pharmacokinetics of a new sublingual formulation of temazepam. European Journal of Clinical Pharmacology 35(4): 437-439

Paulos, C.; Paredes, J.; Vasquez, I.; Thambo, S.; Arancibia, A.; Gonzalez-Martin, G. 1989: Pharmacokinetics of a nitrofuran compound, nifurtimox, in healthy volunteers. International Journal of Clinical Pharmacology Therapy and Toxicology 27(9): 454-457

Bhat, R.; Chari, G.; Gulati, A.; Aldana, O.; Velamati, R.; Bhargava, H. 1990: Pharmacokinetics of a single dose of morphine in preterm infants during the first week of life. Journal of Pediatrics 117(3): 477-481

Crome, P.; Morrison, P.J. 1991: Pharmacokinetics of a single oral dose of lomefloxacin in healthy elderly volunteers. Drug Investigation 3(3): 183-187

Chan, K.K.H.; Ross, H.D.; Berner, B.; Piraino, A.J.; John, V.A. 1990: Pharmacokinetics of a single transdermal dose of nicotine in healthy smokers. Journal of Controlled Release 14(2): 145-152

De Bernardi di Valserra, M.; Germogli, R.; Feletti, F.; Covini, D.; Borgonovo, E. 1992: Pharmacokinetics of a sustained release formulation of pyridoxal phosphate of buflomedil after single or repeated oral doses in healthy volunteers. Arzneimittel-Forschung 42(5): 632-636

Bialer, M.; Haj-Yehia, A.; Barzaghi, N.; Pisani, F.; Perucca, E. 1990: Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects. European Journal of Clinical Pharmacology 38(3): 289-291

Hory, B.; Claudet, M.H.; Magnette, J.; Bechtel, P.; Bayrou, B. 1991: Pharmacokinetic of a very low molecular weight heparin in chronic renal failure. Thrombosis Research 63(3): 311-317

Ahr, H.J.; Boberg, M.; Krause, H.P.; Maul, W.; Mueller, F.O.; Ploschke, H.J.; Weber, H.; Wuensche, C. 1989: Pharmacokinetics of acarbose part i. absorption concentration in plasma metabolism and excretion after single administration of carbon 14 labeled acarbose to rats dogs and man. Arzneimittel-Forschung 39(10): 1254-1260

Ahr, H.J.; Krause, H.P.; Siefert, H.M.; Steinke, W.; Weber, H. 1989: Pharmacokinetics of acarbose part ii. distribution to and elimination form tissues and organs following single or repeated administration of carbon 14 labeled acarbose to rats and dogs. Arzneimittel-Forschung 39(10): 1261-1267

Piquette-Miller, M.; Foster, R.T.; Kappagoda, C.T.; Jamali, F. 1991: Pharmacokinetics of acebutolol enantiomers in humans. Journal of Pharmaceutical Sciences 80(4): 313-316

Macheras, P.; Parissi-Poulos, M.; Poulos, L. 1989: Pharmacokinetics of acetaminophen after intramuscular administration. Biopharmaceutics and Drug Disposition 10(1): 101-105

Mcnamara, P.J.; Burgio, D.; Yoo, S.D. 1991: Pharmacokinetics of acetaminophen, antipyrine, and salicylic acid in the lactating and nursing rabbit, with model predictions of milk to serum concentration ratios and neonatal dose. Toxicology and Applied Pharmacology 109(1): 149-160

Stuck, A.E.; Brindley, C.J.; Busslinger, A.; Frey, F.J. 1989: Pharmacokinetics of acitretin and its 13-cis metabolite in patients on haemodialysis. British Journal of Clinical Pharmacology 27(3): 301-304

Balasubramanian, R.; Klein, K.B.; Pittman, A.W.; Liao, S.H.; Findlay, J.W.; Frosolono, M.F. 1989: Pharmacokinetics of acrivastine after oral and colonic administration. Journal of Clinical Pharmacology 29(5): 444-447

Frenkel, L.M.; Brown, Z.A.; Bryson, Y.J.; Corey, L.; Unadkat, J.D.; Hensleigh, P.A.; Arvin, A.M.; Prober, C.G.; Connor, J.D. 1991: Pharmacokinetics of acyclovir in the term human pregnancy and neonate. American Journal of Obstetrics and Gynecology 164(2): 569-576

Sutter H M.; Ludwig, B.; Bremer, K.D.; Jordan J C.; Rehm, W.F.; Wanner, M. 1991: Pharmacokinetics of aditoprim in dogs after intravenous and oral administration a preliminary study. Journal of Small Animal Practice 32(10): 517-520

Niki, Y.; Bernard, E.M.; Schmitt, H.J.; Tong, W.P.; Edwards, F.F.; Armstrong, D. 1990: Pharmacokinetics of aerosol amphotericin B in rats. Antimicrobial Agents and ChemoTherapy 34(1): 29-32

Guan, T.Y.; Gong, X.Y.; Sun, W.Z.; Liu, S.Z.; Zheng, L.F.; Li, M.G. 1990: Pharmacokinetics of albendazole and its metabolites in human body. Zhongguo Yao Li Xue Bao 11(1): 69-72

Robbins, G.R.; Wynands, J.E.; Whalley, D.G.; Donati, F.; Ramsay, J.G.; Srikant, C.B.; Patel, Y.C. 1990: Pharmacokinetics of alfentanil and clinical responses during cardiac surgery. Canadian Journal of Anaesthesia 37(1): 52-57

Van Beem, H.; Van Peer, A.; Gasparini, R.; Woestenborghs, R.; Heykants, J.; Noorduin, H.; Van Egmond, J.; Crul, J. 1989: Pharmacokinetics of alfentanil during and after a fixed rate infusion. British Journal of Anaesthesia 62(6): 610-615

Davis, P.J.; Killian, A.; Stiller, R.L.; Cook, D.R.; Guthrie, R.D.; Scierka, A.M. 1989: Pharmacokinetics of alfentanil in newborn premature infants and older children. Developmental Pharmacology and Therapeutics 13(1): 21-27

Pukhalsky, A.L.; Toptygina, A.P.; Viktorov, V.V. 1990: Pharmacokinetics of alkylating metabolites of cyclophosphamide in different strains of mice. International Journal of Immunopharmacology 12(2): 217-223

Wilke, A.; Siegmund, W.; Schneider, T.; Wiersbitzky, M.; Franke, G. 1991: Pharmacokinetics of almitrine in healthy volunteers and patients with essential hypertension. Biomedica Biochimica Acta 50(2): 183-187

Grognet, J.M.; Istin, M.; Zanotti, A.; Mailland, F.; Coppi, G. 1991: Pharmacokinetics of alpha-dihydroergokryptine in monkeys after oral administration. Drugs under Experimental and Clinical Research 17(6): 309-312

Dehlin, O.; Kullingsjö, H.; Lidén, A.; Agrell, B.; Moser, G.; Olsen, I. 1991: Pharmacokinetics of alprazolam in geriatric patients with neurotic depression. Pharmacology and Toxicology 68(2): 121-124

Yamamoto, K.; Kohda, Y.; Sawada, Y.; Iga, T. 1991: Pharmacokinetics of ambenonium, a reversible cholinesterase inhibitor, in rats. Biopharmaceutics and Drug Disposition 12(8): 613-625

Tharasse-Bloch, C.; Chabenat, C.; Boucly, P.; Boismare, F.; Marchand, J. 1989: Pharmacokinetics of ambenonium chloride in dogs after intravenous and oral administration. Arzneimittel-Forschung 39(2): 257-258

Mayers, M.; Rush, D.; Madu, A.; Motyl, M.; Miller, M.H. 1991: Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits. Antimicrobial Agents and ChemoTherapy 35(9): 1791-1798

Gronwall, R.; Brown, M.P.; Clubb, S. 1989: Pharmacokinetics of amikacin in African gray parrots. American Journal of Veterinary Research 50(2): 250-252

Kaojarern, S.; Maoleekoonpairoj, S.; Atichartakarn, V. 1989: Pharmacokinetics of amikacin in hematologic malignancies. Antimicrobial Agents and ChemoTherapy 33(8): 1406-1408

Hary, L.; Andrejak, M.; Bernaert, F.; Desablens, B. 1989: Pharmacokinetics of amikacin in neutropenic patients. Current Therapeutic Research 46(5): 821-827

Segal, J.L.; Brunnemann, S.R.; Eltorai, I.M. 1990: Pharmacokinetics of amikacin in serum and in tissue contiguous with pressure sores in humans with spinal cord injury. Antimicrobial Agents and ChemoTherapy 34(7): 1422-1428

Uppal, R.P.; Verma, S.P.; Roy, R.K.; Garg, S.K. 1992: Pharmacokinetics of amikacin sulphate in goats. Indian Journal of Pharmacology 24(2): 123-125

Camus, P.; Coudert, B.; D'Athis, P.; Dumas, M.; Escousse, A.; Jeannin, L. 1990: Pharmacokinetics of amiodarone in the isolated rat lung. Journal of Pharmacology and Experimental Therapeutics 254(1): 336-343

Miyake, K.; Fukuchi, H.; Kitaura, T.; Kimura, M.; Sarai, K.; Nakahara, T. 1990: Pharmacokinetics of amitriptyline and its demethylated metabolite in serum and specific brain regions of rats after acute and chronic administration of amitriptyline. Journal of Pharmaceutical Sciences 79(4): 288-291

Jang I J.; Shin J G.; Shin S G.; Park C W.; Kim J J.; Woo J I.; Cha I J. 1990: Pharmacokinetics of amitriptyline demethylation a crossover study with single doses of amitriptyline and nortriptyline. Seoul Journal of Medicine 31(1): 11-18

Carceles, C.; Sanjuan, M.A.; Hita, J.; Ordonez, D. 1988: Pharmacokinetics of amoxicillin after intravenous administration of single dose in goat. Anales de Veterinaria de Murcia 4: 55-62

Davies, B.E.; Boon, R.; Horton, R.; Reubi, F.C.; Descoeudres, C.E. 1988: Pharmacokinetics of amoxycillin and clavulanic acid in haemodialysis patients following intravenous administration of Augmentin. British Journal of Clinical Pharmacology 26(4): 385-390

Benson, J.M.; Nahata, M.C. 1989: Pharmacokinetics of amphotericin B in children. Antimicrobial Agents and ChemoTherapy 33(11): 1989-1993

Wildfeuer, A.; Müller, V.; Springsklee, M.; Sonntag, H.G. 1991: Pharmacokinetics of ampicillin and sulbactam in patients undergoing heart surgery. Antimicrobial Agents and ChemoTherapy 35(9): 1772-1776

Bailey, J.M.; Levy, J.H.; Rogers, H.G.; Szlam, F.; Hug, C.C. 1991: Pharmacokinetics of amrinone during cardiac surgery. Anesthesiology 75(6): 961-968

Walchshofer, N.; Delatour, P.; Paris, J. 1991: Pharmacokinetics of an anthelmintic potential prodrug of a new benzimidazole in gerbil mouse and sheep. International Journal of Pharmaceutics 77(2-3): 265-268

Sakai, T.; Hamada, T.; Awata, N.; Watanabe, J. 1989: Pharmacokinetics of an antiallergic agent, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1, 4-diazepin-1-yl)-1H-benzimidazole difumarate (KG-2413) after oral administration: interspecies differences in rats, guinea pigs and dogs. Journal of Pharmacobio-Dynamics 12(9): 530-536

Gening, T.P.; Manuĭlov, K.K. 1991: Pharmacokinetics of an antibiotic administered in cell carriers. Antibiotiki i Khimioterapiia 36(9): 19-20

Minami, H.; Horio, Y.; Sakai, S.; Saka, H.; Shimokata, K. 1991: Pharmacokinetics of an etoposide infused over three days: concomitant infusion with cisplatin. Japanese Journal of Clinical Oncology 21(6): 400-405

Kuz'mitskii B.B.; Stoma, O.V.; Slepneva, L.M.; Mashkovich, A.E.; Nasek, V.M.; Gulyakevich, O.V.; Mikhal'chuk A.L. 1989: Pharmacokinetics of an immunomodulator of the d homo 8 azasteroid series. Farmakologiya i Toksikologiya 52(2): 71-74

Massey, N.J.; Sherry, K.M.; Oldroyd, S.; Peacock, J.E. 1990: Pharmacokinetics of an infusion of propofol during cardiac surgery. British Journal of Anaesthesia 65(4): 475-479

Yamamoto, T.; Suzuki, K.; Yamamoto, K.; Adachi, S. 1989: Pharmacokinetics of antimicrobial agents in the elderly. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 26(2): 137-142

Kumon, H.; Mizuno, A.; Nasu, Y.; Tsugawa, M.; Kishi, M.; Ohmori, H. 1989: Pharmacokinetics of arbekacin in healthy volunteers and patients with renal insufficiency. Japanese Journal of Antibiotics 42(1): 200-207

Benakis, A.; Schopfer, C.; Paris, M.; Plessas, C.T.; Karayannakos, P.E.; Dondas, I.; Kotsarelis, D.; Plessas, S.T.; Skalkeas, G. 1991: Pharmacokinetics of arteether in dog. European Journal of Drug Metabolism and Pharmacokinetics 16(4): 325-328

Mueller, W.P.E.; Weiser, P.; Scholler, K.L. 1991: Pharmacokinetics of articaine during mandibular nerve block. Der Anaesthesist 40(5): 52-55

Geyer, J.; Höffler, D.; Koeppe, P. 1988: Pharmacokinetics of aspoxicillin in subjects with normal and impaired renal function. Arzneimittel-Forschung 38(11): 1635-1639

Mehvar, R.; Gross, M.E.; Kreamer, R.N. 1990: Pharmacokinetics of atenolol enantiomers in humans and rats. Journal of Pharmaceutical Sciences 79(10): 881-885

Parker, C.J.; Hunter, J.M. 1989: Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis. British Journal of Anaesthesia 62(2): 177-183

Kent, A.P.; Parker, C.J.; Hunter, J.M. 1989: Pharmacokinetics of atracurium and laudanosine in the elderly. British Journal of Anaesthesia 63(6): 661-666

Schopfer, C.; Pittet, J.F.; Morel, D.R.; Tassonyi, E.; Benakis, A. 1989: Pharmacokinetics of atracurium besylate in the pig after a single i.v. injection. European Journal of Drug Metabolism and Pharmacokinetics 14(4): 299-302

Beemer, G.H.; Bjorksten, A.R.; Crankshaw, D.P. 1990: Pharmacokinetics of atracurium during continuous infusion. British Journal of Anaesthesia 65(5): 668-674

Benn, H.P.; Schnier, C.; Seiler, K.U.; Bauer, E.; Löffler, H. 1990: Pharmacokinetics of auranofin a single dose study in man. Journal of Rheumatology 17(4): 466-468

Adusumalli, V.E.; Wong, K.K.; Kucharczyk, N.; Sofia, R.D. 1992: Pharmacokinetics of azelastine and its active metabolite, desmethylazelastine, in guinea pigs. Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(4): 530-535

Davila, D.; Kolacny-Babić, L.; Plavsić, F. 1991: Pharmacokinetics of azithromycin after single oral dosing of experimental animals. Biopharmaceutics and Drug Disposition 12(7): 505-514

Voigt, R.; Weidt, I.; Schroeder, S.; Brandstaedt, A.; Peiker, G. 1988: Pharmacokinetics of azlocillin after single and repeated intravenous applications during pregnancy. Zentralblatt fuer Gynaekologie 110(15): 944-948

Nagasaka, H.; Inagaki, O.; Nasu, M.; Nakagawa, K.; Nishian, Y.; Hiraoka, K.; Syono, T.; Azuma, M.; Hirabayashi, T.; Mori, H. 1990: Pharmacokinetics of aztreonam on hemodialysis. Japanese Journal of Antibiotics 43(2): 345-354

Segre, G.; Cerretani, D.; Moltoni, L.; Urso, R.; Fusillo, M. 1990: Pharmacokinetics of bamifylline during chronic therapy. Arzneimittel-Forschung 40(4): 450-452

Travis, C.C.; Quillen, J.L.; Arms, A.D. 1990: Pharmacokinetics of benzene. Toxicology and Applied Pharmacology 102(3): 400-420

Baldock, G.A.; Brodie, R.R.; Chasseaud, L.F.; Taylor, T.; Walmsley, L.M.; Catanese, B. 1991: Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects. Biopharmaceutics and Drug Disposition 12(7): 481-492

Hashimoto, Y.; Nakao, K.; Hama, N.; Mukoyama, M.; Imura, H.; Yasuhara, M.; Hori, R. 1992: Pharmacokinetics of brain natriuretic peptide in rats. Chemical and Pharmaceutical Bulletin 40(6): 1650-1652

Zecca, L.; Ferrario, P.; Pirola, R.; Reina, L.; Zambotti, F.; Zonta, N.; Lepore, A.M.; Scaglione, F.; Fraschini, F. 1989: Pharmacokinetics of buflomedil after various dosage forms. Arzneimittel-Forschung 39(4): 518-519

Mazoit, J.X.; Lambert, C.; Berdeaux, A.; Gerard, J.L.; Froideveaux, R. 1988: Pharmacokinetics of bupivacaine after short and prolonged infusions in conscious dogs. Anesthesia and Analgesia 67(10): 961-966

Bricker, S.R.; Telford, R.J.; Booker, P.D. 1989: Pharmacokinetics of bupivacaine following intraoperative intercostal nerve block in neonates and in infants aged less than 6 months. Anesthesiology 70(6): 942-947

Gammans, R.E.; Westrick, M.L.; Shea, J.P.; Mayol, R.F.; LaBudde, J.A. 1989: Pharmacokinetics of buspirone in elderly subjects. Journal of Clinical Pharmacology 29(1): 72-78

Lecaillon, J.B.; Dubois, J.P.; Darragon, T.; Motolese, M.; Racine, A.; Ducret, F.; Grouberman, D.; Cordonnier, D.; Chanard, J.; Glorioso, M. 1991: Pharmacokinetics of cadralazine in a large group of hypertensive patients chronically treated with cadralazine: advantage over a conventional study in a small group of patients. Therapeutic Drug Monitoring 13(2): 103-108

Leonetti, G.; Parini, J.; Visconti, M.; Gradnik, R. 1988: Pharmacokinetics of cadralazine in hypertensive patients. European Journal of Drug Metabolism and Pharmacokinetics 13(4): 295-300

McNamara, P.J.; Burgio, D.; Yoo, S.D. 1992: Pharmacokinetics of caffeine and its demethylated metabolites in lactating adult rabbits and neonatal offspring. Predictions of breast milk to serum concentration ratios. Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(2): 302-308

Aramaki, S.; Suzuki, E.; Ishidaka, O.; Momose, A.; Umemura, K. 1991: Pharmacokinetics of caffeine and its metabolites in horses after intravenous, intramuscular or oral administration. Chemical and Pharmaceutical Bulletin 39(11): 2999-3002

Zysset, T.; Wietholtz, H. 1991: Pharmacokinetics of caffeine in patients with decompensated type i and type Ii diabetes mellitus. European Journal of Clinical Pharmacology 41(5): 449-452

Kanarkowski, R.; Wankiewicz, G.; Lehmann, W.; Rybakowski, J. 1988: Pharmacokinetics of carbamazepine in psychiatric patients. Polish Journal of Pharmacology and Pharmacy 40(1): 55-61

Sweeney, G.; Holbrook, A.M.; Levine, M.; Yip, M.; Alfredsson, K.; Cappi, S.; Ohlin, M.; Schulz, P.; Wassenaar, W. 1990: Pharmacokinetics of carbetocin a long acting oxytocin analogue in nonpregnant women. Current Therapeutic Research 47(3): 528-540

Riva, R.; Manzoni, C.; Mazzetti, A.; Parini, J.; Baruzzi, A. 1988: Pharmacokinetics of carbocalcitonin nasal spray after repeated administration in the healthy volunteer. Rivista di Patologia e Clinica 43(3): 187-196

Tagliaro, F.; Manzoni, C.; Parini, J.; Dorizzi, R.; Mazzetti, A. 1988: Pharmacokinetics of carbocalcitonin nasal spray following single administration in the healthy volunteer. Rivista di Patologia e Clinica 43(1): 65-74

Lucek, R.W.; Dickerson, J.; Carter, D.E.; Bugge, C.J.L.; Crews, T.; Vane, F.M.; Cunningham, W.; Colburn, W.A. 1988: Pharmacokinetics of carbon 14 etretinate in healthy volunteers and two patients with biliary t tube drainage. Biopharmaceutics and Drug Disposition 9(5): 487-500

Efthymiopoulos, C.; Benedetti, M.S.; Sassella, D.; Boobis, A.; Davies, D. 1992: Pharmacokinetics of carbon 14 fce 22891 a penem antibiotic following oral administration to healthy volunteers. Antimicrobial Agents and Chemotherapy 36(9): 1958-1963

Li W J.; Zhen Y X.; Li Y F.; Xi Y L.; Peng X Y.; Hu X.; Zhou X W. 1991: Pharmacokinetics of carboplatin and cisplatin in rats. Zhongguo Yiyao Gongye Zazhi 22(5): 220-223

Mulder, P.O.; de Vries, E.G.; Uges, D.R.; Scaf, A.H.; Sleijfer, D.T.; Mulder, N.H. 1990: Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days. British Journal of Cancer 61(3): 460-464

Zhang M.; Et Al 1991: Pharmacokinetics of carboplatin in cancer patients. Zhonghua Zhongliu Zazhi 13(2): 120-122

Czejka, M.; Jaeger, W.; Schueller, J.; Teherani, D. 1991: Pharmacokinetics of carboplatinum in serum and intraperitoneal fluid after intraperitoneal administration. Archiv der Pharmazie (Weinheim) 324(3): 183-184

Bird, T.G.; Arnould, J.C.; Bertrandie, A.; Jung, F.H. 1992: Pharmacokinetics of catechol cephalosporins. The effect of incorporating substituents into the catechol moiety on pharmacokinetics in a marmoset model. Journal of Medicinal Chemistry 35(14): 2643-2651

Calvo, M.B.; Pedraz, J.L.; Vicente, M.T.; Dominguez Gil, A. 1991: Pharmacokinetics of cefazolin and dibenzylamine administered in a sustained drug delivery system to healthy volunteers. International Journal of Pharmaceutics 67(3): 259-264

Matushek, K.J.; Rosin, E. 1991: Pharmacokinetics of cefazolin applied topically to the surgical wound. Archives of Surgery 126(7): 890-893

Barbhaiya, R.H.; Forgue, S.T.; Gleason, C.R.; Knupp, C.A.; Pittman, K.A.; Weidler, D.J.; Movahhed, H.; Tenney, J.; Martin, R.R. 1992: Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects. Antimicrobial Agents and ChemoTherapy 36(3): 552-557

Barbhaiya, R.H.; Knupp, C.A.; Pfeffer, M.; Zaccardelli, D.; Dukes, G.M.; Mattern, W.; Pittman, K.A.; Hak, L.J. 1992: Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrobial Agents and ChemoTherapy 36(7): 1387-1391

Kovarik, J.M.; ter Maaten, J.C.; Rademaker, C.M.; Deenstra, M.; Hoepelman, I.M.; Hart, H.C.; Matzke, G.R.; Verhoef, J. 1990: Pharmacokinetics of cefepime in patients with respiratory tract infections. Antimicrobial Agents and ChemoTherapy 34(10): 1885-1888

Kees, F.; Naber, K.G. 1990: Pharmacokinetics of cefixime in volunteers compared with newer ester pro drug cephalosporins. Infection 18(Suppl 3): S150-S154

El Guinaidy, M.A.; Nawishy, S.; Abd el Bary, M.; Sabbour, M.S. 1991: Pharmacokinetics of cefodizime in normal individuals and in patients with renal failure. ChemoTherapy 37(2): 77-85

Itagaki, N.; Hasegawa, H.; Sakaguchi, M.; Oono, T.; Iwamoto, I.; Horiuchi, H.; Tsujino, M.; Takahashi, K.; Imada, A.; Horiuchi, A. 1991: Pharmacokinetics of cefodizime in patients undergoing hemodialysis. Japanese Journal of Antibiotics 44(12): 1392-1396

Furlanut, M.; D'Elia, R.; Riva, E.; Pasinelli, F. 1989: Pharmacokinetics of cefonicid in children. European Journal of Clinical Pharmacology 36(1): 79-82

Furlan, G.; Besa, G.; Broccali, G.; Gusmitta, A. 1989: Pharmacokinetics of cefonicid in serum and its penetration into lung tissue, bronchial mucosa and pleura. International Journal of Clinical Pharmacology Research 9(1): 49-53

Ko, R.J.; Sattler, F.R.; Nichols, S.; Akriviadis, E.; Runyon, B.; Appleman, M.; Cohen, J.L.; Koda, R.T. 1991: Pharmacokinetics of cefotaxime and desacetylcefotaxime in patients with liver disease. Antimicrobial Agents and ChemoTherapy 35(7): 1376-1380

Paap, C.M.; Nahata, M.C.; Mentser, M.A.; Mahan, J.D.; Puri, S.K.; Hubbard, J.W. 1991: Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction. Antimicrobial Agents and ChemoTherapy 35(9): 1879-1883

Vincent, P.; Colombel, J.F.; Husson, M.O.; Izard, D.; Paris, J.C.; Leclerc, H. 1988: Pharmacokinetics of cefotaxime in cirrhotic patients with or without ascites. Presse Medicale 17(44): 2331-2334

Kuse, E.; Vogt, P.; Rosenkranz, B. 1990: Pharmacokinetics of cefotaxime in patients after liver transplantation. Infection 18(5): 268-272

Gouyon, J.B.; Pechinot, A.; Safran, C.; Chretien, P.; Sandre, D.; Kazmierczak, A. 1990: Pharmacokinetics of cefotaxime in preterm infants. Developmental Pharmacology and Therapeutics 14(1): 29-34

Zerfowski, M.; Schlegel, P.; Maier, H. 1991: Pharmacokinetics of cefotiam in plasma, parotid saliva and mixed saliva in healthy adults. Arzneimittel-Forschung 41(3): 257-259

Hoeffler, D.; Koeppe, P. 1989: Pharmacokinetics of cefotiam iv in subjects with normal and impaired renal function. Acta Therapeutica 15(1): 3-16

Ohkawa, M.; Tokunaga, S.; Sugata, T.; Shimamura, M.; Okasho, A.; Hirano, S.; Matsui, H. 1989: Pharmacokinetics of cefpiramide in healthy volunteers, patients with various degrees of renal dysfunction, and patients on hemodialysis. ChemoTherapy 35(6): 416-422

Li, C.; Nakayama, S.; Kurosaki, Y.; Nakayama, T.; Kimura, T. 1990: Pharmacokinetics of cefpiramide in rats acutely intoxicated with carbon tetrachloride. Journal of Pharmacobio-Dynamics 13(3): 186-194

Kimura, T.; Yamao, T.; Nakayama, S.; Honge, S.; Kawakami, T.; Kurosaki, Y.; Nakayama, T. 1988: Pharmacokinetics of cefpiramide in rats with obstructive jaundice. Journal of Pharmacobio-Dynamics 11(12): 839-848

Borin, M.T.; Hughes, G.S.; Spillers, C.R.; Patel, R.K. 1990: Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil. Antimicrobial Agents and ChemoTherapy 34(6): 1094-1099

Sáez-Llorens, X.; Shyu, W.C.; Shelton, S.; Kumiesz, H.; Nelson, J. 1990: Pharmacokinetics of cefprozil in infants and children. Antimicrobial Agents and ChemoTherapy 34(11): 2152-2155

Cadórniga, R.; Molina, I.T.; Pastoriza, P.; Negro, S.; Evora, C.M.; Gutierrez, J.A. 1990: Pharmacokinetics of cefroxadine after infusion to healthy volunteers. International Journal of Clinical Pharmacology Therapy and Toxicology 28(10): 435-439

Meulemans, A.; Vicart, P.; Pangon, B.; Mohler, J.; Bocquet, L.; Vulpillat, M. 1989: Pharmacokinetics of cefsulodin in rat cerebrospinal fluid during experimental Pseudomonas aeruginosa meningitis. ChemoTherapy 35(4): 237-241

Jonsson, M.; Walder, M. 1992: Pharmacokinetics of ceftazidime in acutely ill hospitalised elderly patients. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 11(1): 15-21

E.G.inaidy M.A.; Nawishy, S.A.; Abd, E.B.ry M.; Sabbour, M.S. 1991: Pharmacokinetics of ceftazidime in healthy volunteers and renal failure patients. International Journal of Experimental and Clinical Chemotherapy 4(2): 85-93

el Touny, M.; el Guinaidy, M.A.; Abd el Barry, M.; Osman, L.; Sabbour, M.S. 1991: Pharmacokinetics of ceftazidime in patients with liver cirrhosis and ascites. Journal of Antimicrobial ChemoTherapy 28(1): 95-100

Mouton, J.W.; Horrevorts, A.M.; Mulder, P.G.; Prens, E.P.; Michel, M.F. 1990: Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers. Antimicrobial Agents and ChemoTherapy 34(12): 2307-2311

Soback, S.; Ziv, G.; Winkler, M.; Saran, A. 1989: Pharmacokinetics of ceftiofur administered intravenously and intramuscularly to lactating cows. Israel Journal of Veterinary Medicine 45(2): 118-123

L.X.T.; Wang Q N.; Jiang Y F. 1989: Pharmacokinetics of ceftizoxime in humans. Zhongguo Kanfshengsu Zazhi 14(6): 425-432

Westblom, T.U.; Duriex, D.E. 1991: Pharmacokinetics of cefuroxime and ciprofloxacin in gastric mucosa: comparison to in vitro inhibitory concentrations against Helicobacter pylori. Microbiologica 14(1): 37-43

Veyssier, P.; Darchis, J.P.; Devillers, A. 1988: Pharmacokinetics of cefuroxime axetil after oral administration during a six day treatment in elderly patients. Therapie (London/Paris) 43(Suppl 4): 355-360

James, N.C.; Donn, K.H.; Collins, J.J.; Davis, I.M.; Lloyd, T.L.; Hart, R.W.; Powell, J.R. 1991: Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens. Antimicrobial Agents and ChemoTherapy 35(9): 1860-1863

Schoett, D.; Micklefield, G.H.; Zimmermann, I.; Ritzerfeld, W.; Ulmer, W.T. 1991: Pharmacokinetics of cefuroxime axetil in elderly patients with lower respiratory tract infections. Atemwegs-und Lungenkrankheiten 17(1): 29-30

Hoeffler, D.; Koeppe, P.; Schleith, A. 1991: Pharmacokinetics of cefuroxime axetil in patients undergoing hemodialysis therapy. Acta Therapeutica 17(2): 107-122

Powell, D.A.; James, N.C.; Ossi, M.J.; Nahata, M.C.; Donn, K.H. 1991: Pharmacokinetics of cefuroxime axetil suspension in infants and children. Antimicrobial Agents and ChemoTherapy 35(10): 2042-2045

Ito, K.; Hayasaki, M.; Tamaya, T. 1990: Pharmacokinetics of cephem antibiotics in exudate of pelvic retroperitoneal space after radical hysterectomy and pelvic lymphadenectomy. Antimicrobial Agents and ChemoTherapy 34(6): 1160-1164

Schwinghammer, T.L.; Norden, C.W.; Gill, E. 1990: Pharmacokinetics of cephradine administered intravenously and orally to young and elderly subjects. Journal of Clinical Pharmacology 30(10): 893-899

Martin, L.L.; Schaffer, A.V.; Piraino, A.; Linberg, L.; Singh, K.; Rakhit, A.; Douglas, F.L. 1991: Pharmacokinetics of CGS 12970 and inhibition of thromboxane synthesis after oral administration in healthy adults. Clinical Pharmacology and Therapeutics 49(4): 433-441

Dagorn, M.; Guillot, P.; Sanders, P. 1990: Pharmacokinetics of chloramphenicol in sheep after intravenous, intramuscular and subcutaneous administration. Veterinary Quarterly 12(3): 166-174

Bernard, N.; Fauvel, J.P.; Pozet, N.; Ferry, N.; Cuisinaud, G.; Haond, P.; Chapuy, P.; Sassard, J. 1991: Pharmacokinetics of chlormezanone in elderly patients. European Journal of Clinical Pharmacology 41(6): 603-607

Ette, E.I.; Essien, E.E.; Thomas, W.O.; Brown-Awala, E.A. 1989: Pharmacokinetics of chloroquine and some of its metabolites in healthy volunteers: a single dose study. Journal of Clinical Pharmacology 29(5): 457-462

Jungers, P. 1988: Pharmacokinetics of cicletanine in patients with impaired renal function. Drugs under Experimental and Clinical Research 14(2-3): 189-194

Williams, P.E.; Brown, A.N.; Rajaguru, S.; Francis, R.J.; Bell, A.J.; Dewland, P.M. 1990: Pharmacokinetics of cilazapril during repeated oral dosing in healthy young volunteers. European Journal of Drug Metabolism and Pharmacokinetics 15(1): 63-67

McNamara, P.J.; Burgio, D.; Yoo, S.D. 1992: Pharmacokinetics of cimetidine during lactation: species differences in cimetidine transport into rat and rabbit milk. Journal of Pharmacology and Experimental Therapeutics 261(3): 918-923

Kees, F.; Naber, K.G.; Meyer, G.P.; Grobecker, H. 1989: Pharmacokinetics of ciprofloxacin in elderly patients. Arzneimittel-Forschung 39(4): 523-527

Esposito, S.; Miniero, M.; Barba, D.; Sagnelli, E. 1989: Pharmacokinetics of ciprofloxacin in impaired liver function. International Journal of Clinical Pharmacology Research 9(1): 37-41

Ruhnke, M.; Trautmann, M.; Borner, K.; Hopfenmüller, W. 1990: Pharmacokinetics of ciprofloxacin in liver cirrhosis. ChemoTherapy 36(6): 385-391

Ljungberg, B.; Nilsson-Ehle, I. 1989: Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 8(6): 515-520

Suthakaran, C.C.A.; Rajaram, S.; Shashindran, C.H.; Tripathi, K.D.; Gandhi, I.S. 1992: Pharmacokinetics of ciprofloxacin limitation to salivary and urinary sampling. Indian Journal of Pharmacology 24(1): 25-28

Tanabe, N.; Goto, M.; Morita, H.; Gotu, T.; Inagaki, J.; Yamanaki, N.; Kimura, K. 1991: Pharmacokinetics of cis diamminedichloroplatinum in a hemodialysis patient. Cancer Investigation 9(6): 629-636

Milano, G.; Troger, V.; Courdi, A.; Fontana, X.; Chauvel, P.; Lagrange, J.L. 1990: Pharmacokinetics of cisplatin given at a daily low dose as a radiosensitiser. Cancer Chemotherapy and Pharmacology 27(1): 55-59

Motohiro, T.; Yoshinaga, Y.; Sasaki, H.; Oda, K.; Aramaki, M.; Kawakami, A.; Tanaka, K.; Koga, T.; Shimada, Y.; Sakata, Y. 1989: Pharmacokinetics of clarithromycin granule and tablet in children. Japanese Journal of Antibiotics 42(2): 465-494

Laurén, L.; Osterman, T.; Karhi, T. 1991: Pharmacokinetics of clodronate after single intravenous, intramuscular and subcutaneous injections in rats. Pharmacology and Toxicology 69(5): 365-368

Pentikäinen, P.J.; Elomaa, I.; Nurmi, A.K.; Kärkkäinen, S. 1989: Pharmacokinetics of clodronate in patients with metastatic breast cancer. International Journal of Clinical Pharmacology Therapy and Toxicology 27(5): 222-228

Shah, J.; Mason, W.D. 1990: Pharmacokinetics of codeine after parenteral and oral dosing in the rat. Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(5): 670-673

Aweeka, F.T.; Gambertoglio, J.G.; van der Horst, C.; Raasch, R.; Jacobson, M.A. 1992: Pharmacokinetics of concomitantly administered foscarnet and zidovudine for treatment of human immunodeficiency virus infection (AIDS Clinical Trials Group protocol 053). Antimicrobial Agents and ChemoTherapy 36(8): 1773-1778

Rodman, J.H.; Sunderland, M.; Kavanagh, R.L.; Ochs, J.; Yalowich, J.; Evans, W.E.; Rivera, G.K. 1990: Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patients. Cancer Research 50(14): 4267-4271

Ritschel, W.A.; Hussain, A.S.; Skillman, C.A.; Clark, K.E. 1988: Pharmacokinetics of coumarin in pregnant sheep and fetus and in non pregnant sheep. International Journal of Feto-Maternal Medicine 1(2): 4-8

Obach, R.; Colom, H.; Arso, J.; Peraire, C.; Pruñonosa, J. 1989: Pharmacokinetics of cyanamide in dog and rat. Journal of Pharmacy and Pharmacology 41(9): 624-627

Lartigue-Mattei, C.; Chabard, J.L.; Touzet, C.; Chollet, P.; Plagne, R.; Petit, J.; Berger, J.A. 1988: Pharmacokinetics of cyclophosphamide administered alone or in combination with vindesin or cisplatin in 5 patients with bronchial adenocarcinoma. Biomedicine and Pharmacotherapy 42(8): 555-559

Gu, C.N.; Deng, Y.L.; Zhu, Y.H.; Zhu, C.J.; Gu, Q.P. 1991: Pharmacokinetics of cyclosporin A in renal transplant patients after infusion. Zhongguo Yao Li Xue Bao 12(6): 528-530

Luke, D.R.; Brunner, L.J.; Lopez-Berestein, G.; Yau, J.C. 1992: Pharmacokinetics of cyclosporine in bone marrow transplantation: longitudinal characterization of drug in lipoprotein fractions. Journal of Pharmaceutical Sciences 81(3): 208-211

Rand, K.H.; Houck, H.; Ganju, A.; Babington, R.G.; Elfenbein, G.J. 1989: Pharmacokinetics of cytomegalovirus specific IgG antibody following intravenous immunoglobulin in bone marrow transplant patients. Bone Marrow Transplantation 4(6): 679-683

Békássy, A.N.; Liliemark, J.; Garwicz, S.; Wiebe, T.; Gulliksson, H.; Peterson, C. 1990: Pharmacokinetics of cytosine arabinoside in cerebrospinal fluid and of its metabolite in leukemic cells. Medical and Pediatric Oncology 18(2): 136-142

Fraschini, F.; Scaglione, F.; Nebuloni, R.; Falchi, M.; Balsamo, V.; Cattaneo, G. 1989: Pharmacokinetics of dactimicin in rats. Drugs under Experimental and Clinical Research 15(11-12): 541-543

Paul, C.; Liliemark, J.; Tidefelt, U.; Gahrton, G.; Peterson, C. 1989: Pharmacokinetics of daunorubicin and doxorubicin in plasma and leukemic cells from patients with acute nonlymphoblastic leukemia. Therapeutic Drug Monitoring 11(2): 140-148

Nakahama, H.; Izumi, M.; Tanaka, Y.; Wada, A.; Fujita, Y.; Orita, Y.; Shirai, D.; Kamada, T. 1991: Pharmacokinetics of denopamine in hemodialysis patients. Renal Failure 13(1): 37-41

Yasuda, N.; Targ, A.G.; Eger, E.I.; Johnson, B.H.; Weiskopf, R.B. 1990: Pharmacokinetics of desflurane, sevoflurane, isoflurane, and halothane in pigs. Anesthesia and Analgesia 71(4): 340-348

Krause, W.; Kuehne, G.; Sauerbrey, N. 1990: Pharmacokinetics of dextro rolipram and levo rolipram in healthy volunteers. European Journal of Clinical Pharmacology 38(1): 71-76

Pagani, I.; Barzaghi, N.; Crema, F.; Perucca, E.; Ego, D.; Rovei, V. 1989: Pharmacokinetics of dextromoramide in surgical patients. Fundamental and Clinical Pharmacology 3(1): 27-35

Flanagan, R.J.; Johnston, A.; White, A.S.; Crome, P. 1989: Pharmacokinetics of dextropropoxyphene and nordextropropoxyphene in young and elderly volunteers after single and multiple dextropropoxyphene dosage. British Journal of Clinical Pharmacology 28(4): 463-469

Lukey, B.J.; Corcoran, K.D.; Solana, R.P. 1991: Pharmacokinetics of diazepam intramuscularly administered to rhesus monkeys. Journal of Pharmaceutical Sciences 80(10): 918-921

Calvo, M.B.; Pedraz, J.L.; Domínguez-Gil, A. 1990: Pharmacokinetics of dibenzylamine administered in a sustained drug delivery system with cefazolin. Biopharmaceutics and Drug Disposition 11(9): 797-806

Degen, P.H.; Dieterle, W.; Schneider, W.; Theobald, W.; Sinterhauf, U. 1988: Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 18(12): 1449-1455

Ravasco, R.J.; Unadkat, J.D.; Tsai, C.C.; Nosbisch, C. 1992: Pharmacokinetics of dideoxyinosine in pigtailed macaques (Macaca nemestrina) after intravenous and subcutaneous administration. Journal of Acquired Immune Deficiency Syndromes 5(10): 1016-1018

Nuernberg, B.; Koehler, G.; Brune, K. 1991: Pharmacokinetics of diflunisal in patients. Clinical Pharmacokinetics 20(1): 81-89

Lee Y H.; Lee M H.; Shim C K. 1991: Pharmacokinetics of diltiazem and deacetyldiltiazem in rats. International Journal of Pharmaceutics 76(1-2): 71-76

Höglund, P.; Nilsson, L.G. 1989: Pharmacokinetics of diltiazem and its metabolites after repeated single dosing in healthy volunteers. Therapeutic Drug Monitoring 11(5): 551-557

Höglund, P.; Nilsson, L.G. 1989: Pharmacokinetics of diltiazem and its metabolites after single and multiple dosing in healthy volunteers. Therapeutic Drug Monitoring 11(5): 558-566

Dimmitt, D.C.; Yu, D.K.; Elvin, A.T.; Giesing, D.H.; Lanman, R.C. 1991: Pharmacokinetics of diltiazem and propranolol when administered alone and in combination. Biopharmaceutics and Drug Disposition 12(7): 515-523

Kurosawa, S.; Kurosawa, N.; Owada, E.; Soeda, H.; Ito, K. 1990: Pharmacokinetics of diltiazem in patients with liver cirrhosis. International Journal of Clinical Pharmacology Research 10(6): 311-318

Arnera, V.; Wermeille, M.; Wellman, M.; Llull, J.B.; Althaus, M.A.; Balant, L.P. 1990: Pharmacokinetics of dimetindene after intravenous and oral administration to healthy volunteers. Arzneimittel-Forschung 40(12): 1346-1348

Vidal, A.M.; Rey, E.; Pons, G.; Pello, J.Y.; d'Athis, P.; Olive, G. 1992: Pharmacokinetics of diphemanil methylsulphate in healthy subjects. European Journal of Clinical Pharmacology 42(6): 689-691

Yoo, S.D.; Axelson, J.E.; Kwan, E.; Rurak, D.W. 1990: Pharmacokinetics of diphenhydramine after dose ranging in nonpregnant ewes. Journal of Pharmaceutical Sciences 79(2): 106-110

Paterson, S. 1992: Pharmacokinetics of dipipanone after a single oral dose. British Journal of Clinical Pharmacology 33(4): 449-450

Hanhijärvi, H.; Elomaa, I.; Karlsson, M.; Lauren, L. 1989: Pharmacokinetics of disodium clodronate after daily intravenous infusions during five consecutive days. International Journal of Clinical Pharmacology Therapy and Toxicology 27(12): 602-606

Padbury, J.F.; Agata, Y.; Baylen, B.G.; Ludlow, J.K.; Polk, D.H.; Habib, D.M.; Martinez, A.M. 1990: Pharmacokinetics of dopamine in critically ill newborn infants. Journal of Pediatrics 117(3): 472-476

Eldadah, M.K.; Schwartz, P.H.; Harrison, R.; Newth, C.J. 1991: Pharmacokinetics of dopamine in infants and children. Critical Care Medicine 19(8): 1008-1011

Erttmann, R.; Erb, N.; Steinhoff, A.; Landbeck, G. 1988: Pharmacokinetics of doxorubicin in man: dose and schedule dependence. Journal of Cancer Research and Clinical Oncology 114(5): 509-513

Lehmann, K.A.; Van Peer, A.; Ikonomakis, M.; Gasparini, R.; Heykants, J. 1988: Pharmacokinetics of droperidol in surgical patients under different conditions of anaesthesia. British Journal of Anaesthesia 61(3): 297-301

Sue, Y.J.; Shannon, M. 1992: Pharmacokinetics of drugs in overdose. Clinical Pharmacokinetics 23(2): 93-105

Gray, M.R.; Tam, Y.K. 1991: Pharmacokinetics of drugs that inactivate metabolic enzymes. Journal of Pharmaceutical Sciences 80(2): 121-127

Raghoebar, M.; Mak, M.; Cournot, A.; Pistorius, M.C.; Van Harten, J.; Roseboom, H. 1990: Pharmacokinetics of eltoprazine in healthy male subjects after single dose oral and intravenous administration. British Journal of Clinical Pharmacology 30(6): 879-883

van Harten, J.; Mathlener, I.S.; Raghoebar, M. 1990: Pharmacokinetics of eltoprazine in healthy subjects. Drug Metabolism and Drug Interactions 8(1-2): 149-158

Lammers, R.; van Harten, J. 1990: Pharmacokinetics of eltoprazine in the dog. Drug Metabolism and Drug Interactions 8(1-2): 141-148

Wensing, G.; Mönig, H.; Ohnhaus, E.E.; Hoensch, H.P. 1991: Pharmacokinetics of encainide in patients with cirrhosis. Cardiovascular Drugs and Therapy 5(4): 733-739

Dzhanelidze, I.V.; Babukhadia, V.D. 1989: Pharmacokinetics of endolymphatically administered gentamicin in the dog's genitourinary organs. Izvestiya Akademii Nauk Gruzinskoi SSR Seriya Biologicheskaya 15(3): 199-203

Van der Auwera, P.; Stolear, J.C.; George, B.; Dudley, M.N. 1990: Pharmacokinetics of enoxacin and its oxometabolite following intravenous administration to patients with different degrees of renal impairment. Antimicrobial Agents and ChemoTherapy 34(8): 1491-1497

Bowser, P.R.; Wooster, G.A.; St Leger, J.; Babish, J.G. 1992: Pharmacokinetics of enrofloxacin in fingerling rainbow trout (Oncorhynchus mykiss). Journal of Veterinary Pharmacology and Therapeutics 15(1): 62-71

Hosie, J.; Scott, A.K.; Petrie, J.C.; Cockshott, I.D. 1990: Pharmacokinetics of epanolol after acute and chronic oral dosing in elderly patients with stable angina pectoris. British Journal of Clinical Pharmacology 29(3): 333-337

Marlier, R.; McAinsh, J.; Cockshott, I.D. 1990: Pharmacokinetics of epanolol in elderly patients with stable angina pectoris. Arzneimittel-Forschung 40(2 Part 1): 142-144

Dine, T.; Brunet, C.; Luyckx, M.; Cazin, M. 1991: Pharmacokinetics of epirubicin after a single intravenous administration in the rabbit. Acta Therapeutica 17(3): 213-228

Dine, T.; Luyckx, M.; Brunet, C.; Cazin, M. 1991: Pharmacokinetics of epirubicin after intravenous administration: experimental and clinical aspects. Methods and Findings in Experimental and Clinical Pharmacology 13(7): 483-489

Liu, C.G.; Wu, Z.Y.; Li, W.K.; Bai, X.M.; Wu, X.Y.; Xue, T.; Lin, Z.M. 1992: Pharmacokinetics of epostane in rabbits by HPLC method. Zhongguo Yao Li Xue Bao 13(5): 467-470

Kanamoto, I.; Koizumi, T.; Horikoshi, I. 1990: Pharmacokinetics of eptazocine after oral and rectal administration. Yakuzaigaku 50(1): 31-34

Jones, A.W.; Hahn, R.G.; Stalberg, H.P. 1992: Pharmacokinetics of ethanol in plasma and whole blood: estimation of total body water by the dilution principle. European Journal of Clinical Pharmacology 42(4): 445-448

Filser, J.G.; Denk, B.; Törnqvist, M.; Kessler, W.; Ehrenberg, L. 1992: Pharmacokinetics of ethylene in man; body burden with ethylene oxide and hydroxyethylation of hemoglobin due to endogenous and environmental ethylene. Archives of Toxicology 66(3): 157-163

Levron, J.C.; Assoune, P. 1990: Pharmacokinetics of etomidate. Annales Francaises D'anesthesie et de Reanimation 9(2): 123-126

Larsen, F.G.; Nielsen-Kudsk, F.; Jakobsen, P.; Kragballe, K. 1989: Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis. Pharmacology and Toxicology 65(5): 393-397

Björkman, S.; Carlsson, M.; Berntorp, E.; Stenberg, P. 1992: Pharmacokinetics of factor VIII in humans. Obtaining clinically relevant data from comparative studies. Clinical Pharmacokinetics 22(5): 385-395

Andermann, G.; Guggenbuhl, P.; de Burlet, G.; Himber, J. 1989: Pharmacokinetics of falintolol II. Absorption, distribution and elimination from tissues and organs following ocular administration and intravenous injection of falintolol in albino rabbits. Methods and Findings in Experimental and Clinical Pharmacology 11(12): 747-754

Roth, W.; Koss, F.W.; Hallinan, D.; Lambe, R.; Darragh, A. 1990: Pharmacokinetics of falipamil after intravenous administration to humans. Journal of Pharmaceutical Sciences 79(5): 415-419

Ohnishi, K. 1991: Pharmacokinetics of famotidine after intravenous administration in liver disease. American Journal of Gastroenterology 86(1): 41-45

Inotsume, N.; Nishimura, M.; Fujiyama, S.; Sagara, K.; Sato, T.; Imai, Y.; Matsui, H.; Nakano, M. 1989: Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers. European Journal of Clinical Pharmacology 36(5): 517-520

Morgan, M.Y.; Stambuk, D.; Cottrell, J.; Mann, S.G. 1990: Pharmacokinetics of famotidine in normal subjects and in patients with chronic liver disease. Alimentary Pharmacology and Therapeutics 4(1): 83-96

Segre, G.; Auteri, A.; Cerretani, D. 1991: Pharmacokinetics of famotidine in the elderly. Current Therapeutic Research 50(3): 341-347

Saathoff, A.; Lode, H.; Hampel, B.; Deppermann, K.M.; Borner, K.; Koeppe, P. 1990: Pharmacokinetics of FCE 22891, a new oral penem. Antimicrobial Agents and ChemoTherapy 34(6): 1001-1006

Dunselman, P.H.; Edgar, B.; Scaf, A.H.; Kuntze, C.E.; Wesseling, H. 1989: Pharmacokinetics of felodipine after intravenous and chronic oral administration in patients with congestive heart failure. British Journal of Clinical Pharmacology 28(1): 45-52

Edgar, B.; Regårdh, C.G.; Attman, P.O.; Aurell, M.; Herlitz, H.; Johnsson, G. 1989: Pharmacokinetics of felodipine in patients with impaired renal function. British Journal of Clinical Pharmacology 27(1): 67-74

Regårdh, C.G.; Edgar, B.; Olsson, R.; Kendall, M.; Collste, P.; Shansky, C. 1989: Pharmacokinetics of felodipine in patients with liver disease. European Journal of Clinical Pharmacology 36(5): 473-479

Hubbard, J.W.; Marshall, B.D.Jr; Srinivas, N.R.; Bowen, L.L.; Cooper, J.K.; Liberman, R.P.; Midha, K.K. 1992: Pharmacokinetics of fenfluramine and neuroleptics in the treatment of refractory schizophrenia. Drug Investigation 4(2): 99-111

Gauntlett, I.S.; Fisher, D.M.; Hertzka, R.E.; Kuhls, E.; Spellman, M.J.; Rudolph, C. 1988: Pharmacokinetics of fentanyl in neonatal humans and lambs: effects of age. Anesthesiology 69(5): 683-687

Lapka, R.; Smolík, S.; Rejholec, V. 1990: Pharmacokinetics of flobufen and its main active metabolite in the rat. Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(6): 1060-1064

Albani, F.; Riva, F.; Fonio, W.; Mornatti, R.; Nusdeo, O.; Parini, J. 1991: Pharmacokinetics of flomoxef after single intramuscular and intravenous administration in healthy volunteers. Archivio di Medicina Interna 43(1): 53-64

Saito, H.; Kimura, T.; Takeda, T.; Kishimoto, S.; Oguma, T.; Shimamura, K. 1990: Pharmacokinetics of flomoxef in mucosal tissue of the middle ear and mastoid following intravenous administration in humans. ChemoTherapy 36(3): 193-199

Drouet-Coassolo, C.; Iliadis, A.; Coassolo, P.; Antoni, M.; Cano, J.P. 1990: Pharmacokinetics of flunitrazepam following single dose oral administration in liver disease patients compared with healthy volunteers. Fundamental and Clinical Pharmacology 4(6): 643-651

Broggini, M.; Benvenuti, C.; Botta, V.; Broccali, G. 1991: Pharmacokinetics of fluocinolone acetonide in patch versus cream formulations. International Journal of Clinical Pharmacology Research 11(1): 17-21

Barabash, R.D.; Litvin, G.D.; Andreva, K.P.; Petukhov, M.I.; Mironova, M.I.; Normanskii, V.E.; Ryazhskii, G.G.; Kolobanov, A.S. 1990: Pharmacokinetics of fluorescein hematoporphyrin and its derivative during the development of granuloma. Farmakologiya i Toksikologiya 53(6): 48-50

Szpunar, G.J.; Albert, K.S.; Wagner, J.G. 1989: Pharmacokinetics of flurbiprofen in man. II. Plasma protein binding. Research Communications in Chemical Pathology and Pharmacology 64(1): 17-30

Barzaghi, N.; Leone, L.; Monteleone, M.; Tomasini, G.; Perucca, E. 1989: Pharmacokinetics of flutoprazepam, a novel benzodiazepine drug, in normal subjects. European Journal of Drug Metabolism and Pharmacokinetics 14(4): 293-298

Sjövall, J.; Bergdahl, S.; Movin, G.; Ogenstad, S.; Saarimäki, M. 1989: Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection. Antimicrobial Agents and ChemoTherapy 33(7): 1023-1031

Ramis, J.; Torrent, J.; Mis, R.; Barbanoj, M.; Abadias, M.; Jane, F.; Forn, J. 1988: Pharmacokinetics of fosfosal after single and multiple oral doses in man. International Journal of Clinical Pharmacology Therapy and Toxicology 26(9): 421-427

Ramis, J.; Mis, R.; Forn, J. 1989: Pharmacokinetics of fosfosal in rats and dogs. Arzneimittel-Forschung 39(1): 74-77

Xiao, S.H.; Wang, M.J.; You, J.Q.; Jiao, P.Y.; Yang, B.; Chai, J.J. 1991: Pharmacokinetics of four benzimidazoles administered intragastrically to mice infected with secondary cysts of Echinococcus granulosus. Zhongguo Yao Li Xue Bao 12(5): 430-434

Herngren, L.; Nergårdh, A. 1988: Pharmacokinetics of free and total sodium valproate in adolescents and young adults during maintenance therapy. Journal of Neurology 235(8): 491-495

Lakings, D.B.; Friis, J.M.; Lunan, C.M.; Vanderlugt, J.T.; Mohrland, J.S. 1989: Pharmacokinetics of furegrelate after oral administration to normal humans. Pharmaceutical Research 6(1): 53-57

Findon, G.; Miller, T.E.; Rowe, L.C. 1991: Pharmacokinetics of fusidic acid in laboratory animals. Laboratory Animal Science 41(5): 462-465

Mihailova, D.; Yamboliev, I.; Zhivkova, Z.; Tencheva, J.; Jovovich, V. 1989: Pharmacokinetics of galanthamine hydrobromide after single subcutaneous and oral dosage in humans. Pharmacology 39(1): 50-58

Bickel, U.; Thomsen, T.; Weber, W.; Fischer, J.P.; Bachus, R.; Nitz, M.; Kewitz, H. 1991: Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition. Clinical Pharmacology and Therapeutics 50(4): 420-428

Jacqz-Aigrain, E.; Macher, M.A.; Sauvageon-Marthe, H.; Brun, P.; Loirat, C. 1992: Pharmacokinetics of ganciclovir in renal transplant children. Pediatric Nephrology 6(2): 194-196

Gu, C.N.; Shan, H.W.; Deng, Y.L.; Zhu, C.J.; Ding, X.H.; Gu, Q.P. 1992: Pharmacokinetics of gentamicin after intratracheal administration in tracheotomy patients. Zhongguo Yao Li Xue Bao 13(4): 375-376

Buianov, V.M.; Danilov, K.Iu.; Brodinova, N.S.; Khritonov, S.V.; Zaranko, E.I. 1991: Pharmacokinetics of gentamicin after its regional endolymphatic and lymphotropic administration to dogs. Antibiotiki i Khimioterapiia 36(1): 32-34

Southgate, W.M.; DiPiro, J.T.; Robertson, A.F. 1989: Pharmacokinetics of gentamicin in neonates on extracorporeal membrane oxygenation. Antimicrobial Agents and ChemoTherapy 33(6): 817-819

Täuber, U.; Kuhnz, W.; Hümpel, M. 1990: Pharmacokinetics of gestodene and ethinyl estradiol after oral administration of a monophasic contraceptive. American Journal of Obstetrics and Gynecology 163(4 Pt 2): 1414-1420

Vermerie, N.; Kusielewicz, D.; Tod, M.; Nicolas, P.; Perret, G.; Fauvelle, F.; Petitjean, O. 1992: Pharmacokinetics of glafenine and glafenic acid in patients with cirrhosis, compared to healthy volunteers. Fundamental and Clinical Pharmacology 6(4-5): 197-203

Piotrovskii, V.K.; Blagodatskikh, S.V.; Shorr, V.A.; Chichenkov, O.N.; Fel'shtein M.M.; Metelitsa, V.I.; Vasil'ev A.E. 1991: Pharmacokinetics of glycerol trinitrate and isosorbide dinitrate in the application the therapeutic topical systems nitropercuten and sorbopercuten. Khimiko-Farmatsevticheskii Zhurnal 25(6): 7-10

Ishida, S.; Sakiya, Y.; Ichikawa, T.; Awazu, S. 1989: Pharmacokinetics of glycyrrhetic acid, a major metabolite of glycyrrhizin, in rats. Chemical and Pharmaceutical Bulletin 37(9): 2509-2513

Tsai, T.H.; Liao, J.F.; Shum, A.Y.; Chen, C.F. 1992: Pharmacokinetics of glycyrrhizin after intravenous administration to rats. Journal of Pharmaceutical Sciences 81(9): 961-963

Cornelli, U.; Panucci, A.; Zingali, G.; Kirschner, G.; Baggio, C.; Cogo, R. 1990: Pharmacokinetics of GM1 ganglioside following parenteral administration. Journal of Pharmacy and Pharmacology 42(10): 708-711

Gupta, S.K.; Krishnan, R.R.; Ellinwood, E.H.; Ritchie, J.C.; Nemeroff, C.B. 1990: Pharmacokinetics of growth hormone secretion in humans induced by growth hormone releasing hormone. Life Sciences 47(21): 1887-1893

Milton, K.A.; Edwards, G.; Ward, S.A.; Orme, M.L.; Breckenridge, A.M. 1989: Pharmacokinetics of halofantrine in man: effects of food and dose size. British Journal of Clinical Pharmacology 28(1): 71-77

Karbwang, J.; Milton, K.A.; Na Bangchang, K.; Ward, S.A.; Edwards, G.; Bunnag, D. 1991: Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria. British Journal of Clinical Pharmacology 31(4): 484-487

Wiles, D.H.; Mccreadie, R.G.; Whitehead, A. 1990: Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia. Psychopharmacology 101(2): 274-281

Oh-e, Y.; Miyazaki, H.; Matsunaga, Y.; Hashimoto, M. 1991: Pharmacokinetics of haloperidol decanoate in rats. Journal of Pharmacobio-Dynamics 14(11): 615-622

Chen W H.; Xu D Y. 1990: Pharmacokinetics of hematoporphyrin monomethyl ether psd 044 in rabbits. Zhongguo Yiyao Gongye Zazhi 21(1): 7-9

Barabash, R.D.; Skobelkin, O.K.; Petukhov, M.I.; Normanskii, V.E.; Ryazhskii, G.G.; Mironova, M.I.; Andreeva, K.P.; Kolobanov, A.S. 1990: Pharmacokinetics of hematoporphyrin of its derivative and fluorescein during the development of carcinosarcoma. Farmakologiya i Toksikologiya 53(3): 24-26

Segre, G.; Cerretani, D.; Baldi, A.; Urso, R. 1992: Pharmacokinetics of heptastigmine in rats. Pharmacological Research 25(2): 139-146

Boonstra-Nieveld, I.H.; van Bezooijen, C.F. 1989: Pharmacokinetics of hexobarbital in young and old rats. Mechanisms of Ageing and Development 50(3): 289-298

Kletzel, M.; Kearns, G.L.; Wells, T.G.; Thompson, H.C. 1992: Pharmacokinetics of high dose thiotepa in children undergoing autologous bone marrow transplantation. Bone Marrow Transplantation 10(2): 171-175

L.Y.; Zhang H L.; Liang M Z.; Chen, Z.; Xie X H.; Zhang N C. 1991: Pharmacokinetics of home made ceftriaxone in patients with acute infections. Zhongguo Kangshengsu Zazhi 16(2): 117-120

Tsukerman, E.S.; Poznanskaya, A.A.; Kholodov, L.E.; Dorokhov, V.V.; Klement'eva I.V.; Smirnova, T.N.; Avakumov, V.M.; Kurganov, B.I. 1988: Pharmacokinetics of hydroxycobalamins adenosylcobalamins cyanocobalamins administered orally to rats. Khimiko-Farmatsevticheskii Zhurnal 22(8): 907-911

Oelschlaeger, H.; Rothley, D.; Hellwich K H.; Schmidt, W. 1989: Pharmacokinetics of hypolipidemic agents is 2 4 hydroxyphenoxy 2 methylpropionic acid a metabolite of the hypolipidemic agent ciprofibrate 2 4 2 2 dichlorocyclopropylphenoxy 2 methylpropanoic acid?. Archiv der Pharmazie (Weinheim) 322(6): 337-342

Oelschlaeger, H.; Rothley, D.; Hellwich, K.H.; Schmidt, W. 1989: Pharmacokinetics of hypolipidemic agents vi. is 2 4 2 2 dichlorocyclopropylphenoxypropane a metabolite of the hypolipidemic agent ciprofibrate. Archiv der Pharmazie (Weinheim) 322(10): 629-632

Oelschlaeger, H.; Kohl, C.; Armstrong, D.W.; Rothley, D. 1991: Pharmacokinetics of hypolipidemic agents viii. unequivocal determination of ciprofibrate o beta d glucuronide. Archiv der Pharmazie (Weinheim) 324(8): 505-508

Oliary, J.; Tod, M.; Nicolas, P.; Petitjean, O.; Caillé, G. 1992: Pharmacokinetics of ibuprofen enantiomers after single and repeated doses in man. Biopharmaceutics and Drug Disposition 13(5): 337-344

Beck, W.S.; Geisslinger, G.; Engler, H.; Brune, K. 1991: Pharmacokinetics of ibuprofen enantiomers in dogs. Chirality 3(3): 165-169

Perez, J.H.; Fos, D.; Alamo, C.; Martin Martin, F.; Suarez, J.R.; Montes Jovellar, B. 1989: Pharmacokinetics of ibuprofen following oral administration of single dose lobuprofen in healthy volunteers. Revista de Farmacologia Clinica y Experimental 6(2): 89-95

Robert, J.; Rigal-Huguet, F.; Huet, S.; Pris, J.; Hurteloup, P. 1990: Pharmacokinetics of idarubicin after oral administration in elderly leukemic patients. Leukemia 4(3): 227-229

Hildebrand, M.; Krause, W.; Fabian, H.; Koziol, T.; Neumayer, H.H. 1990: Pharmacokinetics of iloprost in patients with chronic renal failure and on maintenance haemodialysis. International Journal of Clinical Pharmacology Research 10(5): 285-292

Hildebrand, M.; Krause, W.; Angeli, P.; Koziol, T.; Gatta, A.; Merkel, C.; Bolognesi, M. 1990: Pharmacokinetics of iloprost in patients with hepatic dysfunction. International Journal of Clinical Pharmacology Therapy and Toxicology 28(10): 430-434

Janmohamed, R.M.; Leyland, M.J.; Kelly, J.; Farrell, I. 1990: Pharmacokinetics of imipenem/cilastatin in neutropenic patients with haematological malignancies. Journal of Antimicrobial ChemoTherapy 25(3): 407-412

Erttmann, M.; Krausse, R.; Ullmann, U. 1990: Pharmacokinetics of imipenem in patients undergoing major colon surgery. Infection 18(6): 367-371

Signs, S.A.; Tan, J.S.; Salstrom, S.J.; File, T.M. 1992: Pharmacokinetics of imipenem in serum and skin window fluid in healthy adults after intramuscular or intravenous administration. Antimicrobial Agents and ChemoTherapy 36(7): 1400-1403

Bernareggi, A.; Danese, A.; Cometti, A.; Buniva, G.; Rowland, M. 1990: Pharmacokinetics of individual components of teicoplanin in man. Journal of Pharmacokinetics and Biopharmaceutics 18(6): 525-543

Aweeka, F.; Gambertoglio, J.; Mills, J.; Jacobson, M.A. 1989: Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis. Antimicrobial Agents and ChemoTherapy 33(5): 742-745

Mogg, G.A.; Triggs, E.J.; Ismail, Z.; Higbie, J.; Frost, M. 1990: Pharmacokinetics of interpleural bupivacaine in patients undergoing cholecystectomy. British Journal of Anaesthesia 64(6): 657-661

Andersson, M.; Aronsen, K.F.; Balch, C.; Domellof, L.; Eksborg, S.; Hafstrom, L.O.; Howell, S.B.; Karesen, R.; Midander, J.; Teder, H. 1990: Pharmacokinetics of intra arterial mitomycin c with or without degradable starch microspheres dsm in the treatment of resectable liver cancer. Oncologia 13(6): 277-281

Neander, G.; Eriksson, L.O.; Wållin-Boll, E.; Ersmark, H.; Grahnen, A. 1992: Pharmacokinetics of intraarticular indomethacin in patients with osteoarthritis. European Journal of Clinical Pharmacology 42(3): 301-305

Verdier, F.; Pussard, E.; Clavier, F.; Le Bras, J.; Gaudebout, C. 1989: Pharmacokinetics of intramuscular amopyroquin in healthy subjects and determination of a therapeutic regimen for Plasmodium falciparum malaria. Antimicrobial Agents and ChemoTherapy 33(3): 316-321

Koopman-Kimenai, P.M.; Vree, T.B.; Booij, L.H.; Dirksen, R.; Nijhuis, G.M. 1991: Pharmacokinetics of intramuscular nicomorphine and its metabolites in man. European Journal of Clinical Pharmacology 41(4): 375-378

Dharmasena, D.; Roberts, D.E.; Coles, G.A.; Williams, J.D. 1989: Pharmacokinetics of intraperitoneal ciprofloxacin in patients on CAPD. Journal of Antimicrobial ChemoTherapy 23(2): 253-259

Montaldo, P.G.; Figoli, F.; Zanette, M.L.; Sorio, R.; Zucchetti, M.; Tirelli, U.; D'Incalci, M. 1990: Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion. Oncology 47(1): 55-61

Jones, A.E.; Barnes, N.D.; Tasker, T.C.; Horton, R. 1990: Pharmacokinetics of intravenous amoxycillin and potassium clavulanate in seriously ill children. Journal of Antimicrobial ChemoTherapy 25(2): 269-274

Naito, H. 1988: Pharmacokinetics of intravenous and epidural buprenorphine analgesia. Masui. Japanese Journal of Anesthesiology 37(10): 1180-1191

Olkkola, K.T.; Maunuksela, E.L.; Korpela, R. 1989: Pharmacokinetics of intravenous buprenorphine in children. British Journal of Clinical Pharmacology 28(2): 202-204

Sánchez-Alcaraz, A.; Ibáñez, P.; Sangrador, G. 1991: Pharmacokinetics of intravenous caffeine in critically ill patients. Journal of Clinical Pharmacy and Therapeutics 16(4): 285-289

Creasey, W.A.; Morrison, R.A.; Singhvi, S.M.; Willard, D.A. 1988: Pharmacokinetics of intravenous captopril in healthy men. European Journal of Clinical Pharmacology 35(4): 367-370

Hayton, W.L.; Walstad, R.A.; Thurmann-Nielsen, E.; Kufaas, T.; Kneer, J.; Ambros, R.J.; Rugstad, H.E.; Monn, E.; Bodd, E.; Stoeckel, K. 1991: Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children. Antimicrobial Agents and Chemotherapy 35(4): 720-725

Stoeckel, K. 1991: Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in human subjects a review. Drug Investigation 3(5): 291-298

Hayton, W.L.; Kneer, J.; Blouin, R.A.; Stoeckel, K. 1990: Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis. Antimicrobial Agents and ChemoTherapy 34(7): 1318-1322

Kneer, J.; Tam, Y.K.; Blouin, R.A.; Frey, F.J.; Keller, E.; Stathakis, C.; Luginbuehl, B.; Stoeckel, K. 1989: Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency. Antimicrobial Agents and ChemoTherapy 33(11): 1952-1957

Tan, J.S.; Salstrom, S.J.; Signs, S.A.; Hoffman, H.E.; File, T.M. 1989: Pharmacokinetics of intravenous cefmetazole with emphasis on comparison between predicted theoretical levels in tissue and actual skin window fluid levels. Antimicrobial Agents and ChemoTherapy 33(6): 924-927

Weiss, L.G.; Cars, O.; Danielson, B.G.; Grahnen, A.; Wikström, B. 1988: Pharmacokinetics of intravenous cefuroxime during intermittent and continuous arteriovenous hemofiltration. Clinical Nephrology 30(5): 282-286

Whitehead, E.M.; Walters, G.E.; Williams, P.E.; Johnston, G.D. 1989: Pharmacokinetics of intravenous cilazaprilat in normal volunteers. British Journal of Clinical Pharmacology 27(6): 873-875

Ljungberg, B.; Nilsson-Ehle, I. 1988: Pharmacokinetics of intravenous ciprofloxacin at three different doses. Journal of Antimicrobial ChemoTherapy 22(5): 715-720

Carceles, C.; Sanjuan, M.A.; Hita, J.; Ordonez, D. 1988: Pharmacokinetics of intravenous clavulanic acid after single dose in goats. Anales de Veterinaria de Murcia 4: 47-54

Lerman, J.; McLeod, M.E.; Strong, H.A. 1989: Pharmacokinetics of intravenous dantrolene in children. Anesthesiology 70(4): 625-629

Korpela, R.; Olkkola, K.T. 1990: Pharmacokinetics of intravenous diclofenac sodium in children. European Journal of Clinical Pharmacology 38(3): 293-295

Tawashi, M.; Marc-Aurèle, J.; Bichet, D.; Spénard, J.; Larivière, L.; Plante, D.; Caillé, G. 1991: Pharmacokinetics of intravenous diltiazem and five of its metabolites in patients with chronic renal failure and in healthy volunteers. Biopharmaceutics and Drug Disposition 12(2): 105-112

Alarabi, A.A.; Cars, O.; Danielson, B.G.; Salmonson, T.; Wikström, B. 1990: Pharmacokinetics of intravenous imipenem/cilastatin during intermittent haemofiltration. Journal of Antimicrobial ChemoTherapy 26(1): 91-98

Weisman, L.E.; Fischer, G.W.; Marinelli, P.; Hemming, V.G.; Pierce, J.R.; Golden, S.M.; Peck, C.C. 1989: Pharmacokinetics of intravenous immunoglobulin in neonates. Vox Sanguinis 57(4): 243-248

Noya, F.J.; Rench, M.A.; Courtney, J.T.; Feldman, S.; Baker, C.J. 1989: Pharmacokinetics of intravenous immunoglobulin in very low birth weight neonates. Pediatric Infectious Disease Journal 8(11): 759-763

Lau, A.H.; Emmons, K.; Seligsohn, R. 1991: Pharmacokinetics of intravenous metronidazole at different dosages in healthy subjects. International Journal of Clinical Pharmacology Therapy and Toxicology 29(10): 386-390

Sánchez-Alcaraz, A.; Sangrador, G.; Laguarda, M.; Quintana, B. 1991: Pharmacokinetics of intravenous midazolam during epidural anaesthesia. Journal of Clinical Pharmacy and Therapeutics 16(3): 209-214

Salmonson, T.; Danielson, B.G.; Grahnén, A.; Wikström, B. 1990: Pharmacokinetics of intravenous recombinant human erythropoietin in patients with chronic renal failure. Journal of Internal Medicine 228(1): 53-57

Rey, E.; Luquel, L.; Richard, M.O.; Mory, B.; Offenstadt, G.; Olive, G. 1989: Pharmacokinetics of intravenous salbutamol in renal insufficiency and its biological effects. European Journal of Clinical Pharmacology 37(4): 387-389

Hultquist, C.; Lindberg, C.; Nyberg, L.; Kjellman, B.; Wettrell, G. 1989: Pharmacokinetics of intravenous terbutaline in asthmatic children. Developmental Pharmacology and Therapeutics 13(1): 11-20

Ko, H.; Cathcart, K.S.; Griffith, D.L.; Peters, G.R.; Adams, W.J. 1989: Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination. Antimicrobial Agents and Chemotherapy 33(3): 356-361

Dalton, J.T.; Wientjes, M.G.; Badalament, R.A.; Drago, J.R.; Au, J.L. 1991: Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients. Cancer Research 51(19): 5144-5152

Ben-Nun, J.; Joyce, D.A.; Cooper, R.L.; Cringle, S.J.; Constable, I.J. 1989: Pharmacokinetics of intravitreal injection. Assessment of a gentamicin model by ocular dialysis. IOVS Investigative Ophthalmology and Visual Science 30(6): 1055-1061

Lamka, J. 1992: Pharmacokinetics of inulin in blood and central lymph in the rat. Polish Journal of Pharmacology and Pharmacy 44(2): 147-152

Edwards, D.M.; Marrari, P.; Efthymiopoulos, C.; Basileo, G.; Fraier, D.; Pianezzola, E.; Strolin-Benedetti, M. 1991: Pharmacokinetics of iododoxorubicin in the rat, dog, and monkey. Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(5): 938-945

Corradi, A.; Menta, R.; Cambi, V.; Maccarini, P.; Cerutti, R. 1990: Pharmacokinetics of iopamidol in adults with renal failure. Arzneimittel-Forschung 40(7): 830-832

Evans, J.R.; Cutler, R.E.; Forland, S.C. 1988: Pharmacokinetics of iothalamate in endstage renal disease. Journal of Clinical Pharmacology 28(9): 826-830

Ensing, K.; de Zeeuw, R.A.; Nossent, G.D.; Koëter, G.H.; Cornelissen, P.J. 1989: Pharmacokinetics of ipratropium bromide after single dose inhalation and oral and intravenous administration. European Journal of Clinical Pharmacology 36(2): 189-194

Cotting, J.; Reichen, J.; Kutz, K.; Laplanche, R.; Nüesch, E. 1990: Pharmacokinetics of isradipine in patients with chronic liver disease. European Journal of Clinical Pharmacology 38(6): 599-603

Lebrec, D.; Hadengue, A.; Gaudin, C.; Levron, J.C.; Fraitag, B.; Berthelot, P.; Benhamou, J.P. 1990: Pharmacokinetics of ketanserin in patients with cirrhosis. Clinical Pharmacokinetics 19(2): 160-166

Foster, R.T.; Jamali, F.; Russell, A.S. 1989: Pharmacokinetics of ketoprofen enantiomers in cholecystectomy patients: influence of probenecid. European Journal of Clinical Pharmacology 37(6): 589-594

Flouvat, B.; Roux, A.; Delhotal-Landes, B. 1989: Pharmacokinetics of ketoprofen in man after repeated percutaneous administration. Arzneimittel-Forschung 39(7): 812-815

Satterwhite, J.H.; Boudinot, F.D. 1992: Pharmacokinetics of ketoprofen in rats: effect of age and dose. Biopharmaceutics and Drug Disposition 13(3): 197-212

Jung, D.; Mroszczak, E.; Bynum, L. 1988: Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration. European Journal of Clinical Pharmacology 35(4): 423-425

Grahnén, A.; Lönnebo, A.; Beck, O.; Eckernäs, S.A.; Dahlström, B.; Lindström, B. 1992: Pharmacokinetics of ketotifen after oral administration to healthy male subjects. Biopharmaceutics and Drug Disposition 13(4): 255-262

Priest, D.G.; Schmitz, J.C.; Bunni, M.A.; Stuart, R.K. 1991: Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously. Journal of the National Cancer Institute 83(24): 1806-1812

Greiner, P.O.; Zittoun, J.; Marquet, J.; Cheron, J.M. 1989: Pharmacokinetics of levo folinic acid after oral and intravenous administration of the racemate. British Journal of Clinical Pharmacology 28(3): 289-296

Laguarda Rodrigo, M.; Sangrador Garcia, G.; Sanchez Alcaraz, A. 1990: Pharmacokinetics of lidocaine after interscalene administration in brachial plexus blocking. Farmacia Clinica 7(2): 117-118, 120-121

Burm, A.G.; Van Kleef, J.W.; Vermeulen, N.P.; Olthof, G.; Breimer, D.D.; Spierdijk, J. 1988: Pharmacokinetics of lidocaine and bupivacaine following subarachnoid administration in surgical patients: simultaneous investigation of absorption and disposition kinetics using stable isotopes. Anesthesiology 69(4): 584-592

Le Normand, Y.; de Dieuleveult, C.; Athouel, A.; Queinnec, M.C.; de Villepoix, C.; Larousse, C. 1989: Pharmacokinetics of lidocaine and bupivacaine in retrobulbar and facial block. Fundamental and Clinical Pharmacology 3(2): 95-102

Satoh, Y. 1988: Pharmacokinetics of lidocaine and monoethylglycinexylidide after the intratracheal administration of lidocaine. Masui. Japanese Journal of Anesthesiology 37(10): 1192-1198

Burrows, F.A.; Lerman, J.; LeDez, K.M.; Strong, H.A. 1991: Pharmacokinetics of lidocaine in children with congenital heart disease. Canadian Journal of Anaesthesia 38(2): 196-200

Santos, A.C.; Pedersen, H.; Morishima, H.O.; Finster, M.; Arthur, G.R.; Covino, B.G. 1988: Pharmacokinetics of lidocaine in nonpregnant and pregnant ewes. Anesthesia and Analgesia 67(12): 1154-1158

Katagiri, E.; Sakai, M.; Horikawa, H. 1991: Pharmacokinetics of lidocaine in perfused rat liver. Masui. Japanese Journal of Anesthesiology 40(1): 80-90

Loginov, A.S.; Nilova, T.V.; Bendikov, E.A.; Petrakov, A.V. 1989: Pharmacokinetics of lipoic acid preparations and their effects on atp synthesis processes of microsomal and cytosol oxidation in human hepatocytes in liver damage. Farmakologiya i Toksikologiya 52(4): 78-82

Kelly, J.G.; Doyle, G.D.; Carmody, M.; Glover, D.R.; Cooper, W.D. 1988: Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis. British Journal of Clinical Pharmacology 26(6): 781-786

Vitiello, B.; Behar, D.; Malone, R.; Delaney, M.A.; Ryan, P.J.; Simpson, G.M. 1988: Pharmacokinetics of lithium carbonate in children. Journal of Clinical Psychopharmacology 8(5): 355-359

Gros, I.; Carbon, C. 1990: Pharmacokinetics of lomefloxacin in healthy volunteers: comparison of 400 milligrams once daily and 200 milligrams twice daily given orally for 5 days. Antimicrobial Agents and ChemoTherapy 34(1): 150-152

Hoeffler, D.; Waetcke, K.; Koeppe, P.; Metz, R.; Soergel, F. 1989: Pharmacokinetics of lomefloxacin in normal and impaired renal function. Acta Therapeutica 15(4): 321-336

Blum, R.A.; Schultz, R.W.; Schentag, J.J. 1990: Pharmacokinetics of lomefloxacin in renally compromised patients. Antimicrobial Agents and ChemoTherapy 34(12): 2364-2368

Matzke, G.R.; Halstenson, C.E.; Opsahl, J.A.; Hilbert, J.; Perentesis, G.; Radwanski, E.; Zampaglione, N. 1990: Pharmacokinetics of loratadine in patients with renal insufficiency. Journal of Clinical Pharmacology 30(4): 364-371

Mcdermott, C.A.; Kowalczyk, A.L.; Schnitzler, E.R.; Mangurten, H.H.; Rodvold, K.A.; Metrick, S. 1992: Pharmacokinetics of lorazepam in critically ill neonates with seizures. Journal of Pediatrics 120(3): 479-483

Miyake, K.; Fukuchi, H.; Kitaura, T.; Kimura, M.; Kimura, Y.; Nakahara, T. 1991: Pharmacokinetics of maprotiline and its demethylated metabolite in serum and specific brain regions of rats after acute and chronic administration of maprotiline. Journal of Pharmaceutical Sciences 80(12): 1114-1118

Mallo, C.; Zaĭdan, R.; Galy, G.; Vermeulen, E.; Brun, J.; Chazot, G.; Claustrat, B. 1990: Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection. European Journal of Clinical Pharmacology 38(3): 297-301

Todd, E.L.; Stafford, D.T.; Bucovaz, E.T.; Morrison, J.C. 1989: Pharmacokinetics of meperidine in pregnancy. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 29(2): 143-146

Burman, L.A.; Nilsson-Ehle, I.; Hutchison, M.; Haworth, S.J.; Norrby, S.R. 1991: Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem. Journal of Antimicrobial ChemoTherapy 27(2): 219-224

Ljungberg, B.; Nilsson-Ehle, I. 1992: Pharmacokinetics of meropenem and its metabolite in young and elderly healthy men. Antimicrobial Agents and ChemoTherapy 36(7): 1437-1440

Mouton, J.W.; Michel, M.F. 1991: Pharmacokinetics of meropenem in serum and suction blister fluid during continuous and intermittent infusion. Journal of Antimicrobial ChemoTherapy 28(6): 911-918

Leroy, A.; Fillastre, J.P.; Etienne, I.; Borsa-Lebás, F.; Humbert, G. 1992: Pharmacokinetics of meropenem in subjects with renal insufficiency. European Journal of Clinical Pharmacology 42(5): 535-538

Christensson, B.A.; Nilsson-Ehle, I.; Hutchison, M.; Haworth, S.J.; Oqvist, B.; Norrby, S.R. 1992: Pharmacokinetics of meropenem in subjects with various degrees of renal impairment. Antimicrobial Agents and ChemoTherapy 36(7): 1532-1537

Vlahov, V.; Badian, M.; Verho, M.; Bacracheva, N. 1990: Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium. European Journal of Clinical Pharmacology 38(1): 61-65

Bougerolle, A.M.; Chabard, J.L.; Eschalier, A.; Aumaitre, O.; Fialip, J.; Dordain, G.; Petit, J.; Berger, J.A. 1989: Pharmacokinetics of metapramine and its demethylated metabolites in plasma and brain of mice. Fundamental and Clinical Pharmacology 3(5): 515-525

Zhang Z G.; Xiong C S. 1990: Pharmacokinetics of methimidol hydrochloride and a comparison of bioavailability between its capsules and tablets. Zhongguo Yaolixue Yu Dulixue Zazhi 4(4): 286-288

Foussadier, A.; Boulieu, R.; Lehot, J.J.; Ferry, S. 1991: Pharmacokinetics of methohexital during cardiovascular surgery with cardiopulmonary bypass. Fundamental and Clinical Pharmacology 5(7): 595-600

Brooks, P.J.; Spruill, W.J.; Parish, R.C.; Birchmore, D.A. 1990: Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis. Arthritis and Rheumatism 33(1): 91-94

Yoon, E.J.; Lee, M.G.; Lee H J.; Park, M.K.; Kim C K. 1990: Pharmacokinetics of methotrexate after intramuscular injection of methotrexate polylysine conjugate in rabbits. Archives of Pharmacal Research 13(2): 147-150

Yoon, E.J.; Chang, H.W.; Lee, M.G.; Lee, H.; Park, M.K.; Kim, C.K. 1991: Pharmacokinetics of methotrexate after intravenous infusion of methotrexate rabbit serum albumin conjugate to rabbits. International Journal of Pharmaceutics 67(2): 177-184

Morikawa, N.; Tsukamoto, T.; Nakano, M.; Yoshida, T.; Oka, S.; Okada, K.; Ueno, R.; Terada, H. 1991: Pharmacokinetics of methotrexate and 7 hydroxymethotrexate in patients with high dose methotrexate. Yakuzaigaku 51(2): 115-122

Skibińska, L.; Daszkiewicz, P.; Michalewska, D.; Radwańska, U. 1988: Pharmacokinetics of methotrexate given intrathecally to children with acute lymphoblastic leukemia. Polish Journal of Pharmacology and Pharmacy 40(2): 135-143

Miller, K.T.; Wilkinson, D.S. 1989: Pharmacokinetics of methotrexate in the cerebrospinal fluid after intracerebroventricular administration in patients with meningeal carcinomatosis and altered cerebrospinal fluid flow dynamics. Therapeutic Drug Monitoring 11(3): 231-237

Bourget, P.; Fernandez, H.; Lesne, A.; Delouis, C.; Frydman, R. 1991: Pharmacokinetics of methotrexate used as medical treatment of unruptured ectopic pregnancy clinical response. Therapie (London/Paris) 46(5): 399-404

W.M.Y.; Johansson, J.; Altman, N.H.; Haynes, D.H.; Fiserova Bergerova, V. 1989: Pharmacokinetics of methoxyflurane after its intra dermal injection as lecithin coated microdroplets. Journal of Controlled Release 9(1): 1-12

Li D.; Zhu M.; Yang X Y.; Cheng W B.; Mo G Q.; Wang X F. 1991: Pharmacokinetics of methyl tert butyl ether mtbe in rats. Zhongguo Yaolixue Yu Dulixue Zazhi 5(4): 287-289

Tsukerman, E.S.; Kholodov, L.E.; Poznanskaya, A.A. 1991: Pharmacokinetics of methylcobalamin in rats. Khimiko-Farmatsevticheskii Zhurnal 25(11): 13-15

Bredberg, U.; Paalzow, L. 1990: Pharmacokinetics of methysergide and its metabolite methylergometrine in the rat. Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(3): 338-343

Magueur, E.; Hagege, H.; Attali, P.; Singlas, E.; Etienne, J.P.; Taburet, A.M. 1991: Pharmacokinetics of metoclopramide in patients with liver cirrhosis. British Journal of Clinical Pharmacology 31(2): 185-187

Abdi, Y.A.; Villén, T. 1991: Pharmacokinetics of metrifonate and its rearrangement product dichlorvos in whole blood. Pharmacology and Toxicology 68(2): 137-139

Mustofa; Suryawati, S.; Santoso, B. 1991: Pharmacokinetics of metronidazole in saliva. International Journal of Clinical Pharmacology Therapy and Toxicology 29(12): 474-478

Grech-Bélanger, O.; Barbeau, G.; Kishka, P.; Fiset, C.; LeBoeuf, E.; Blouin, M. 1989: Pharmacokinetics of mexiletine in the elderly. Journal of Clinical Pharmacology 29(4): 311-315

Amendt, K.; Hild, R. 1990: Pharmacokinetics of mezlocillin after intraarterial or intravenous injection in patients with peripheral arterial occlusive disease (PAOD). Vasa. Zeitschrift für Gefasskrankheiten 19(2): 161-166

Nomura, H.; Yamada, F.; Hakusui, H. 1990: Pharmacokinetics of midaglizole, a new hypoglycaemic agent, in healthy subjects. Biopharmaceutics and Drug Disposition 11(8): 701-713

Malacrida, R.; Fritz, M.E.; Suter, P.M.; Crevoisier, C. 1992: Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Critical Care Medicine 20(8): 1123-1126

Jacqz-Aigrain, E.; Daoud, P.; Burtin, P.; Maherzi, S.; Beaufils, F. 1992: Pharmacokinetics of midazolam during continuous infusion in critically ill neonates. European Journal of Clinical Pharmacology 42(3): 329-332

Pentikäinen, P.J.; Välisalmi, L.; Himberg, J.J.; Crevoisier, C. 1989: Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects. Journal of Clinical Pharmacology 29(3): 272-277

Rey, E.; Delaunay, L.; Pons, G.; Murat, I.; Richard, M.O.; Saint-Maurice, C.; Olive, G. 1991: Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration. European Journal of Clinical Pharmacology 41(4): 355-357

Jacqz-Aigrain, E.; Wood, C.; Robieux, I. 1990: Pharmacokinetics of midazolam in critically ill neonates. European Journal of Clinical Pharmacology 39(2): 191-192

Maitre, P.O.; Funk, B.; Crevoisier, C.; Ha, H.R. 1989: Pharmacokinetics of midazolam in patients recovering from cardiac surgery. European Journal of Clinical Pharmacology 37(2): 161-166

Imbimbo, B.P.; Urso, R.; Thieme, G.; Sturn, B.; Ueckert, B.; Vidi, A.; Ladinsky, H.; Daniotti, S. 1988: Pharmacokinetics of mifentidine after single and multiple oral administration to healthy volunteers. British Journal of Clinical Pharmacology 26(4): 407-413

Miglioli, P.A.; Pivetta, P.; Orlando, R.; Palatini, P.; Varotto, A.; Okolicsanyi, L. 1989: Pharmacokinetics of miocamycin in patients with liver cirrhosis. ChemoTherapy 35(5): 330-332

Oie, S.; Guentert, T.W.; Tolentino, L.; Hermodsson, G. 1992: Pharmacokinetics of moclobemide in male, virgin female, pregnant and nursing rats. Journal of Pharmacy and Pharmacology 44(5): 413-418

Spreux-Varoquaux, O.; Doll, J.; Dutot, C.; Grandjean, N.; Cordonnier, P.; Pays, M.; Andrieu, J.; Advenier, C. 1991: Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis. British Journal of Clinical Pharmacology 32(3): 399-401

Mallinger, A.G.; Smith, E. 1991: Pharmacokinetics of monoamine oxidase inhibitors. Psychopharmacology Bulletin 27(4): 493-502

Manara, A.R.; Shelly, M.P.; Quinn, K.G.; Park, G.R. 1989: Pharmacokinetics of morphine following administration by the buccal route. British Journal of Anaesthesia 62(5): 498-502

Drost, R.H.; Ionescu, T.I.; Taverne, R.H.; van Lingen, G.; van Rossum, J.M.; Maes, R.A. 1988: Pharmacokinetics of morphine in cerebrospinal fluid and plasma after epidural administration in man. Arzneimittel-Forschung 38(11): 1632-1634

Shelly, M.P.; Quinn, K.G.; Park, G.R. 1989: Pharmacokinetics of morphine in patients following orthotopic liver transplantation. British Journal of Anaesthesia 63(4): 375-379

Ross, H.D.; Chan, K.K.; Piraino, A.J.; John, V.A. 1991: Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers. Pharmaceutical Research 8(3): 385-388

Rasheed, A.; Alam, M.; Subhan, F. 1987: Pharmacokinetics of n methylisatin 3 thiosemicarbazone in rabbit. Pakistan Veterinary Journal 7(4): 142-144

Zhou, X.J.; Boré, P.; Monjanel, S.; Sahnoun, Z.; Favre, R.; Durand, A.; Rahmani, R. 1991: Pharmacokinetics of navelbine after oral administration in cancer patients. Cancer Chemotherapy and Pharmacology 29(1): 66-70

Errecalde, J.O.; Lanusse, C.E.; Landoni, M.F. 1990: Pharmacokinetics of neomycin in sheep after intravenous, intramuscular, subcutaneous and intratracheal administration. Zentralblatt für Veterinarmedizin. Reihe A 37(3): 163-169

Herrero, A.; Rius Alarcó, F.; García-Díez, J.M.; Mahiques, E.; Domingo, J.V. 1988: Pharmacokinetics of netilmicin during hemodialysis: comparison of four artificial kidneys. International Journal of Clinical Pharmacology Therapy and Toxicology 26(12): 605-609

Notsuka, T.; Furusawa, M.; Kawakita, K. 1991: Pharmacokinetics of netilmicin in patients after abdominal surgery. Japanese Journal of Antibiotics 44(8): 846-853

Verghese, C.; Kessel, J.B.; Simpson, G.M. 1991: Pharmacokinetics of neuroleptics. Psychopharmacology Bulletin 27(4): 551-563

Molinaro, M.; Villa, G.; Regazzi, M.B.; Salvadeo, A.; Segagni, S.; Rondanelli, R.; Sartirana, E. 1992: Pharmacokinetics of nicorandil in patients with normal and impaired renal function. European Journal of Clinical Pharmacology 42(2): 203-207

Caspary, S.; Keller Stanislawski, B.; Huber, T.; Merz P G. 1991: Pharmacokinetics of nicotine after application of a 30 square centimeter squared nicotine patch under steady state conditions. International Journal of Clinical Pharmacology Therapy and Toxicology 29(3): 92-95

Avgerinos, A.; Gorrod, J.W. 1990: Pharmacokinetics of nifedipine derived from a new retard tablet formulation. European Journal of Drug Metabolism and Pharmacokinetics 15(4): 273-278

Banditt, P.; Meyer, F.P. 1990: Pharmacokinetics of nifedipine following oral and sublingual application. Zeitschrift fuer Klinische Medizin 45(14): 1243-1244

Leucuta, S.E.; Grigorescu, M.; Dumitrascu, D. 1990: Pharmacokinetics of nifedipine in patients with hepatic cirrhosis after administering a unique oral dose. Revista de Medicina Interna Neurologie Psihiatrie Neurochirurgie Dermato-Venerologie Serie Medicina Interna 42(2): 185-190

Cheung, W.K.; Woodward, D.L.; Shin, K.; Hibberd, M.; Pearse, S.; Desjardins, R.E.; Yacobi, A.; Silber, B.M. 1988: Pharmacokinetics of nilvadipine after single oral doses in healthy volunteers. International Journal of Clinical Pharmacology Research 8(5): 299-305

Eicher, H.; Hilgert, D.; Zeeh, J.; Platt, D.; Becker, C.; Mutschler, E. 1992: Pharmacokinetics of nimodipine in multimorbid elderly patients with chronic brain failure. Archives of Gerontology and Geriatrics 14(3): 309-319

He H.; Sun S.; Lin S.; Xi N. 1990: Pharmacokinetics of nitrendipine in rabbits by plasma hplc analysis. Journal of Shanghai Medical University 17(6): 473-476

van Bortel, L.; Böhm, R.; Mooy, J.; Schiffers, P.; Rahn, K.H. 1989: Pharmacokinetics of nitrendipine in terminal renal failure. European Journal of Clinical Pharmacology 36(5): 467-471

Yu, D.K.; Williams, R.L.; Benet, L.Z.; Lin, E.T.; Giesing, D.H. 1988: Pharmacokinetics of nitroglycerin and metabolites in humans following oral dosing. Biopharmaceutics and Drug Disposition 9(6): 557-565

Korman, D.B.; Kim, O.A.; Gor'kov V.A. 1988: Pharmacokinetics of nitrosomethylurea in cancer patients. Voprosy Onkologii (St Petersburg) 34(6): 694-699

Sano, H.; Sato, H.; Furuta, S.; Mogi, M.; Matsuki, Y.; Motogi, M. 1991: Pharmacokinetics of nizatidine in dogs and rats. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 21(10): 1257-1264

Saperstein, S.; Edgren, R.A.; Jung, D.; Mroszczak, E.J.; Lee, G.J.; Dorr, A.; Pritchard, R.; Kushinsky, S.; Fong, J.C.; Combs, D.L. 1989: Pharmacokinetics of norethindrone: effect of particle size. Contraception 40(6): 731-740

Sang, G.W.; Liu, X.H.; Shao, Q.X.; Ge, J.L.; Mao, S.M.; Lu, F.Y. 1991: Pharmacokinetics of norethindrone enanthate 200 mg after intramuscular injection in 25 Chinese women. Zhongguo Yao Li Xue Bao 12(2): 184-187

Sivakumar, B.; Prasad, K.V.; Ravinder, P.; Ramalakshmi, B.A.; Narasinga Rao, B.S. 1989: Pharmacokinetics of norethisterone from two different combination contraceptive pills in Indian women. Indian Journal of Physiology and Pharmacology 33(1): 10-14

Lepage, J.Y.; Caillon, J.; Malinowsky, J.M.; Lequerré, S.; Cozian, A.; Le Normand, Y.; Potel, G.; Drugeon, H.; Baron, D. 1991: Pharmacokinetics of norfloxacin in the elderly. Fundamental and Clinical Pharmacology 5(3): 203-208

Farinotti, R.; Trouvin, J.H.; Bocquet, V.; Vermerie, N.; Carbon, C. 1988: Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects. Antimicrobial Agents and ChemoTherapy 32(10): 1590-1592

Molinaro, M.; Villani, P.; Regazzi, M.B.; Rondanelli, R.; Doveri, G. 1992: Pharmacokinetics of ofloxacin in elderly patients and in healthy young subjects. European Journal of Clinical Pharmacology 43(1): 105-107

Flor, S.; Guay, D.; Opsahl, J.; Tack, K.; Matzke, G. 1991: Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment. International Journal of Clinical Pharmacology Research 11(3): 115-121

Bandai, H.; Tsubakihara, Y.; Yamato, E.; Yokoyama, K.; Okada, N.; Nakanishi, I.; Iida, N. 1989: Pharmacokinetics of ofloxacin in severe chronic renal failure. Clinical Therapeutics 11(2): 210-218

Andersson, T.; Regardh C G. 1990: Pharmacokinetics of omeprazole and metabolites following single intravenous and oral doses of 40 and 80mg. Drug Investigation 2(4): 255-263

Rinetti, M.; Regazzi, M.B.; Villani, P.; Tizzoni, M.; Sivelli, R. 1991: Pharmacokinetics of omeprazole in cirrhotic patients. Arzneimittel-Forschung 41(4): 420-422

Miles, M.V.; Balasubramanian, R.; Pittman, A.W.; Grossman, S.H.; Pappa, K.A.; Smith, M.F.; Wargin, W.A.; Findlay, J.W.; Poust, R.I.; Frosolono, M.F. 1990: Pharmacokinetics of oral and transdermal triprolidine. Journal of Clinical Pharmacology 30(6): 572-575

Couet, W.; Fauvel, J.P.; Laville, M.; Pozet, N.; Fourtillan, J.B. 1991: Pharmacokinetics of oral cefatrizine in patients with impaired renal function. International Journal of Clinical Pharmacology Therapy and Toxicology 29(6): 213-217

Sudo, R.T.; Melo, P.A.; Suarez-Kurtz, G. 1990: Pharmacokinetics of oral ciprofloxacin in healthy, young Brazilian subjects. Brazilian Journal of Medical and Biological Research 23(12): 1315-1321

Tawashi, M.; Marc-Aurèle, J.; Bichet, D.; Spénard, J.; Larivière, L.; Plante, D.; Caillé, G. 1991: Pharmacokinetics of oral diltiazem and five of its metabolites in patients with chronic renal failure. Biopharmaceutics and Drug Disposition 12(2): 95-104

Osterborg, A.; Ehrsson, H.; Eksborg, S.; Wallin, I.; Mellstedt, H. 1989: Pharmacokinetics of oral melphalan in relation to renal function in multiple myeloma patients. European Journal of Cancer and Clinical Oncology 25(5): 899-903

Hoyo-Vadillo, C.; Castañeda-Hernández, G.; Herrera, J.E.; Vidal-Gárate, J.; Salazar, L.A.; Moreno-Ramos, A.; Chávez, F.; Tena, I.; Hong, E. 1989: Pharmacokinetics of oral nifedipine: relevance of the distribution phase. Journal of Clinical Pharmacology 29(3): 251-256

Karlsson, M.O.; Dahlström, B.; Eckernäs, S.A.; Johansson, M.; Alm, A.T. 1990: Pharmacokinetics of oral noscapine. European Journal of Clinical Pharmacology 39(3): 275-279

Buoncuore, A.; Poirier, J.M.; Jaillon, P.; Ferry, A.; Pochmalicki, G.; Colombel, B.; Vrancea, F.; Cheymol, G.; Valty, J. 1989: Pharmacokinetics of oral propafenone in patients with supraventricular arrhythmia. Therapie 44(2): 79-85

Kokue, E.; Shimoda, M.; Sakurada, K.; Wada, J. 1988: Pharmacokinetics of oral sulfa drugs and gastric emptying in the pig. Journal of Pharmacobio-Dynamics 11(8): 549-554

Caritis, S.N.; Venkataramanan, R.; Cotroneo, M.; Chiao, J.P. 1989: Pharmacokinetics of orally administered ritodrine. American Journal of Obstetrics and Gynecology 161(1): 32-35

Morse, G.D.; Olson, J.; Portmore, A.; Taylor, C.; Plank, C.; Reichman, R.C. 1989: Pharmacokinetics of orally administered zidovudine among patients with hemophilia and asymptomatic human immunodeficiency virus (HIV) infection. Antiviral Research 11(2): 57-65

Lecaillon, J.B.; Dubois, J.P.; Coppens, H.; Darragon, T.; Reumond, G.; Pozet, N.; Traeger, J.; Lambrey, G. 1990: Pharmacokinetics of oxiracetam in patients with renal impairment after a 800 mg single oral dose. European Journal of Drug Metabolism and Pharmacokinetics 15(3): 231-237

Mondal, T.K.; Sarkar, S.; Mishra, S.K.; Ghose, R.K.; Chakraborty, A.K. 1990: Pharmacokinetics of oxytetracycline in experimentally induced hypomagnesemia in goats. Indian Journal of Pharmacology 22(4): 245-249

Mandal, T.K.; Sarkar, S.; Chakraborty, A.K.; Ghose, R.K. 1992: Pharmacokinetics of oxytetracycline in presence of calcium gluconate in goats. Indian Journal of Physiology and Pharmacology 36(2): 112-114

Regardh, C.G.; Heggelund, A.; Kylberg-Hanssen, K.; Lundborg, P. 1990: Pharmacokinetics of pafenolol after i.v. and oral administration of three separate doses of different strength to man. Biopharmaceutics and Drug Disposition 11(7): 607-617

Lenneräs, H.; Regårdh, C.G. 1990: Pharmacokinetics of pafenolol in the rat: a suitable model for studying absorption mechanisms of a drug exhibiting unusual absorption properties in man. Biopharmaceutics and Drug Disposition 11(7): 619-631

Leyvraz, S.; Hess, U.; Flesch, G.; Bauer, J.; Hauffe, S.; Ford, J.M.; Burckhardt, P. 1992: Pharmacokinetics of pamidronate in patients with bone metastases. Journal of the National Cancer Institute 84(10): 788-792

Kupriyanov Ashin, E.G.; Kurinenko, B.M.; Potselueva, L.A.; Zaikonnikova, I.V. 1988: Pharmacokinetics of pancreatic and microbial rnases. Khimiko-Farmatsevticheskii Zhurnal 22(10): 1165-1171

Wierda, J.M.; van der Starre, P.J.; Scaf, A.H.; Kloppenburg, W.D.; Proost, J.H.; Agoston, S. 1990: Pharmacokinetics of pancuronium in patients undergoing coronary artery surgery with and without low dose dopamine. Clinical Pharmacokinetics 19(6): 491-498

Ritschel, W.A.; Kraus, C.; Shaaya, A.; Sakr, A. 1991: Pharmacokinetics of papaverine HCl upon intravenous route of administration in old and young beagle dogs. Methods and Findings in Experimental and Clinical Pharmacology 13(1): 51-55

Hopkins, C.S.; Underhill, S.; Booker, P.D. 1990: Pharmacokinetics of paracetamol after cardiac surgery. Archives of Disease in Childhood 65(9): 971-976

Gawrońska-Szklarz, B.; Gabriel, J.; Wójcicki, J. 1988: Pharmacokinetics of paracetamol in patients with stomach cancer. Polish Journal of Pharmacology and Pharmacy 40(1): 41-45

Dalhoff, K.; Almdal, T.P.; Bjerrum, K.; Keiding, S.; Mengel, H.; Lund, J. 1991: Pharmacokinetics of paroxetine in patients with cirrhosis. European Journal of Clinical Pharmacology 41(4): 351-354

Scott, R.T.; Ross, B.; Anderson, C.; Archer, D.F. 1991: Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol. Obstetrics and Gynecology 77(5): 758-764

Devissaguet, J.P.; Ammoury, N.; Devissaguet, M.; Perret, L. 1990: Pharmacokinetics of perindopril and its metabolites in healthy volunteers. Fundamental and Clinical Pharmacology 4(2): 175-189

Chen, Z.R.; Bochner, F.; Somogyi, A. 1988: Pharmacokinetics of pholcodine in healthy volunteers: single and chronic dosing studies. British Journal of Clinical Pharmacology 26(4): 445-453

Lukey, B.J.; Parrish, J.H.; Marlow, D.D.; Clark, C.R.; Sidell, F.R. 1990: Pharmacokinetics of physostigmine intramuscularly administered to guinea pigs. Journal of Pharmaceutical Sciences 79(9): 796-798

Neugebauer, G.; Wittenbrink-Dix, A.M.; Woelke-Seidl, E.; Kaufmann, B.; Ponton, T.; Dahmen, W.; Mosberg, H.; Nieder, N.; Besenfelder, E. 1989: Pharmacokinetics of picumast dihydrochloride and its active metabolites M1 and M2 in humans. Arzneimittel-Forschung 39(10a): 1336-1339

Neugebauer, G.; Raedsch, R.; Stiehl, A.; Kaufmann, B.; Besenfelder, E.; Neubert, P.; Walter-Sack, I. 1989: Pharmacokinetics of picumast dihydrochloride in patients with liver cirrhosis. Arzneimittel-Forschung 39(10a): 1343-1347

Heikkilä, A.; Erkkola, R. 1991: Pharmacokinetics of piperacillin during pregnancy. Journal of Antimicrobial ChemoTherapy 28(3): 419-423

Debruyne, D.; Ryckelynck, J.P.; Hurault De Ligny, B.; Moulin, M. 1990: Pharmacokinetics of piperacillin in patients on peritoneal dialysis with and without peritonitis. Journal of Pharmaceutical Sciences 79(2): 99-102

Nagasawa, K.; Yokoyama, T.; Ohnishi, N.; Iwakawa, S.; Okumura, K.; Kosaka, Y.; Sano, K.; Murakami, R.; Nakamura, H. 1991: Pharmacokinetics of pirarubicin in pediatric patients. Journal of Pharmacobio-Dynamics 14(4): 222-230

Rossi, F.A.; Ferrero, M.; Balladore, G.E.; Zecca, L.; Fraschini, F.; Ferrario, P.; Bichisao, E.; Monza, G.C.; Maresca, V. 1988: Pharmacokinetics of pirprofen and its pyrrol metabolite in elderly patients. European Journal of Clinical Pharmacology 35(4): 379-383

Hallé, F.; Marfil, F.; Sioufi, A.; Dubois, J.P.; Gioud-Paquet, M.; Lenoir, G.; Prieur, A.M. 1991: Pharmacokinetics of pirprofen in children with juvenile chronic arthritis. European Journal of Drug Metabolism and Pharmacokinetics 16(1): 29-34

Kulik, G.I.; Solyannik, G.I.; Lipovoi, A.S.; Bagiryan, M.A.; Biryuk, L.I. 1991: Pharmacokinetics of platinum in patients with small cell lung cancer. Voprosy Onkologii (St Petersburg) 37(5): 568-571

Olkkola, K.T.; Maunuksela, E.L.; Korpela, R. 1989: Pharmacokinetics of postoperative intravenous indomethacin in children. Pharmacology and Toxicology 65(2): 157-160

Jovanović, D. 1989: Pharmacokinetics of pralidoxime chloride. A comparative study in healthy volunteers and in organophosphorus poisoning. Archives of Toxicology 63(5): 416-418

Kajiyama, H.; Fujimura, A.; Ebihara, A.; Hino, Y. 1991: Pharmacokinetics of pranoprofen in the elderly. International Journal of Clinical Pharmacology Research 11(3): 123-127

Miller, P.F.; Bowmer, C.J.; Wheeldon, J.; Brocklebank, J.T. 1990: Pharmacokinetics of prednisolone in children with nephrosis. Archives of Disease in Childhood 65(2): 196-200

Rostin, M.; Barthe, P.; Houin, G.; Alvinerie, M.; Bouissou, F. 1990: Pharmacokinetics of prednisolone in children with the nephrotic syndrome. Pediatric Nephrology 4(5): 470-473

Chosidow, O.; Etienne, S.D.; Diquet, B.; Vandermeersch, V.; Vu-Thi-My-Le, C.; Herson, S.; Puech, A.J. 1991: Pharmacokinetics of prednisone and prednisolone in bullous pemphigoid patients. International Journal of Clinical Pharmacology Therapy and Toxicology 29(9): 376-380

Paar, W.D.; Brockmeier, D.; Hirzebruch, M.; Schmidt, E.K.; von Unruh, G.E.; Dengler, H.J. 1990: Pharmacokinetics of prenylamine racemate and enantiomers in man. Arzneimittel-Forschung 40(6): 657-661

Lur'e, A.A.; Ovusu, A.; Ozeretskovskaya, N.N. 1988: Pharmacokinetics of preparations for the control of onchocerciasis communication iii. diethylcarbamazine. Meditsinskaya Parazitologiya i Parazitarnye Bolezni 2: 41-46

Chang I J.; Shin J G.; Shin S G.; Park C W.; Lim J K. 1989: Pharmacokinetics of procainamide and n acetylprocainamide. Korean Journal of Pharmacology 25(1): 101-108

Mehvar, R. 1990: Pharmacokinetics of propafenone enantiomers in rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(6): 987-991

Hu O.Y P.; Liou W S.; Su T J.; Chiam S F.; Lai J S.; Chu M L.; Chung P H. 1989: Pharmacokinetics of properties of intramuscular gentamicin in chinese subjects. International Journal of Pharmaceutics 53(1): 85-89

Karbwang, J.; Bangchang, K.N.; Supapojana, A.; Bunnag, D.; Harinasuta, T. 1991: Pharmacokinetics of prophylactic mefloquine in Thai healthy volunteers. Southeast Asian Journal of Tropical Medicine and Public Health 22(1): 68-71

Kirvelä, M.; Olkkola, K.T.; Rosenberg, P.H.; Yli-Hankala, A.; Salmela, K.; Lindgren, L. 1992: Pharmacokinetics of propofol and haemodynamic changes during induction of anaesthesia in uraemic patients. British Journal of Anaesthesia 68(2): 178-182

Jones, R.D.; Chan, K.; Andrew, L.J. 1990: Pharmacokinetics of propofol in children. British Journal of Anaesthesia 65(5): 661-667

Gin, T.; Gregory, M.A.; Chan, K.; Buckley, T.; Oh, T.E. 1990: Pharmacokinetics of propofol in women undergoing elective caesarean section. British Journal of Anaesthesia 64(2): 148-153

Saint-Maurice, C.; Cockshott, I.D.; Douglas, E.J.; Richard, M.O.; Harmey, J.L. 1989: Pharmacokinetics of propofol in young children after a single dose. British Journal of Anaesthesia 63(6): 667-670

Servin, F.; Cockshott, I.D.; Farinotti, R.; Haberer, J.P.; Winckler, C.; Desmonts, J.M. 1990: Pharmacokinetics of propofol infusions in patients with cirrhosis. British Journal of Anaesthesia 65(2): 177-183

Morgan, D.J.; Campbell, G.A.; Crankshaw, D.P. 1990: Pharmacokinetics of propofol when given by intravenous infusion. British Journal of Clinical Pharmacology 30(1): 144-148

Keuth, V.; Rohdewald, P. 1989: Pharmacokinetics of propyphenazone. PZ (Pharmazeutische Zeitung) Wissenschaft 134(2): 21-26

Jin, X.L.; Zhu, X.Y. 1992: Pharmacokinetics of puerarin in rats, rabbits, and dogs. Zhongguo Yao Li Xue Bao 13(3): 284-288

Lacroix, C.; Hoang, T.P.; Nouveau, J.; Guyonnaud, C.; Laine, G.; Duwoos, H.; Lafont, O. 1989: Pharmacokinetics of pyrazinamide and its metabolites in healthy subjects. European Journal of Clinical Pharmacology 36(4): 395-400

Lacroix, C.; Tranvouez, J.L.; Phan Hoang, T.; Duwoos, H.; Lafont, O. 1990: Pharmacokinetics of pyrazinamide and its metabolites in patients with hepatic cirrhotic insufficiency. Arzneimittel-Forschung 40(1): 76-79

Berg, S.L.; Balis, F.M.; McCully, C.L.; Godwin, K.S.; Poplack, D.G. 1991: Pharmacokinetics of pyrazoloacridine in the rhesus monkey. Cancer Research 51(20): 5467-5470

Taylor, T.; Hawkins, D.R.; Forrest, T.J.; Chung, H. 1991: Pharmacokinetics of pyridostigmine in dogs. Journal of Pharmaceutical Sciences 80(4): 353-356

Swartz, R.D.; Starmann, B.; Horvath, A.M.; Olson, S.C.; Posvar, E.L. 1990: Pharmacokinetics of quinapril and its active metabolite quinaprilat during continuous ambulatory peritoneal dialysis. Journal of Clinical Pharmacology 30(12): 1136-1141

Blum, R.A.; Olson, S.C.; Kohli, R.K.; Horvath, A.M.; Sedman, A.J.; Posvar, E.L. 1990: Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis. Journal of Clinical Pharmacology 30(10): 938-942

Verme, C.N.; Ludden, T.M.; Clementi, W.A.; Harris, S.C. 1992: Pharmacokinetics of quinidine in male patients. a population analysis. Clinical Pharmacokinetics 22(6): 468-480

Couet, W.; Laroche, R.; Floch, J.J.; Istin, B.; Fourtillan, J.B.; Sauniere, J.F. 1991: Pharmacokinetics of quinine and doxycycline in patients with acute falciparum malaria: a study in Africa. Therapeutic Drug Monitoring 13(6): 496-501

Salako, L.A.; Sowunmi, A.; Akinbami, F.O. 1989: Pharmacokinetics of quinine in African children suffering from kwashiorkor. British Journal of Clinical Pharmacology 28(2): 197-201

Madsen, P.O.; Aagaard, J. 1991: Pharmacokinetics of quinolone derivatives in the prostate. Infection 19(Suppl): S154-S156

Movin-Osswald, G.; Nordström, A.L.; Hammarlund-Udenaes, M.; Wahlén, A.; Farde, L. 1992: Pharmacokinetics of raclopride formulations. Influence of prolactin and tolerability in healthy male volunteers. Clinical Pharmacokinetics 22(2): 152-161

Harada, A.; Inenaga, T.; Washio, M. 1988: Pharmacokinetics of ramipril in chronic renal failure. Current Therapeutic Research 44(2): 200-212

Schunkert, H.; Kindler, J.; Gassmann, M.; Lahn, W.; Irmisch, R.; Ritz, E.; Debusmann, E.R.; Pujadas, J.O.; Koch, K.M.; Sieberth, H.G. 1989: Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency. European Journal of Clinical Pharmacology 37(3): 249-256

Makil, O.; Kaltenbach, M.L.; Limberg, J.; Harrison, D.; Hocking, M.P.; Derendorf, H. 1991: Pharmacokinetics of ranitidine after partial gastrectomy in dogs. Journal of Pharmaceutical Sciences 80(11): 1034-1036

Wiest, D.B.; O'Neal, W.; Reigart, J.R.; Brundage, R.C.; Gillette, P.C.; Yost, R.L. 1989: Pharmacokinetics of ranitidine in critically ill infants. Developmental Pharmacology and Therapeutics 12(1): 7-12

Platt, D.; Bauer, M.; Eicher, H. 1989: Pharmacokinetics of ranitidine in geriatric patients with multiple diseases. Archives of Gerontology and Geriatrics 8(2): 139-150

Davis, R.L.; Quenzer, R.W.; Bozigian, H.P.; Warner, C.W. 1990: Pharmacokinetics of ranitidine in morbidly obese women. Dicp: the Annals of PharmacoTherapy 24(11): 1040-1043

Gladziwa, U.; Krishna, D.R.; Klotz, U.; Ittel, T.H.; Schunkert, H.; Glöckner, W.M.; Mann, H. 1988: Pharmacokinetics of ranitidine in patients undergoing haemofiltration. European Journal of Clinical Pharmacology 35(4): 427-430

Nielsen, O.J. 1990: Pharmacokinetics of recombinant human erythropoietin in chronic haemodialysis patients. Pharmacology and Toxicology 66(2): 83-86

Kampf, D.; Eckardt, K.U.; Fischer, H.C.; Schmalisch, C.; Ehmer, B.; Schostak, M. 1992: Pharmacokinetics of recombinant human erythropoietin in dialysis patients after single and multiple subcutaneous administrations. Nephron 61(4): 393-398

Macdougall, I.C.; Roberts, D.E.; Neubert, P.; Dharmasena, A.D.; Coles, G.A.; Williams, J.D. 1989: Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Lancet 1(8635): 425-427

Tanaka, H.; Kaneko, T. 1991: Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies. Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(1): 200-204

Silverman, H.S.; Siddoway, L.A.; Yavin, Z.; Gonenne, A.; Weisfeldt, M.L.; Becker, L.C. 1990: Pharmacokinetics of recombinant human superoxide dismutase. Journal of Cardiovascular Pharmacology 16(1): 107-111

Greischel, A.; Zahn, G. 1989: Pharmacokinetics of recombinant human tumor necrosis factor alpha in rhesus monkeys after intravenous administration. Journal of Pharmacology and Experimental Therapeutics 251(1): 358-361

Konrad, M.W.; Hemstreet, G.; Hersh, E.M.; Mansell, P.W.; Mertelsmann, R.; Kolitz, J.E.; Bradley, E.C. 1990: Pharmacokinetics of recombinant interleukin 2 in humans. Cancer Research 50(7): 2009-2017

Landsdorp, D.; Vree, T.B.; Janssen, T.J.; Guelen, P.J. 1990: Pharmacokinetics of rectal diclofenac and its hydroxy metabolites in man. International Journal of Clinical Pharmacology Therapy and Toxicology 28(7): 298-302

Pedraz, J.L.; Calvo, M.B.; Lanao, J.M.; Muriel, C.; Santos Lamas, J.; Domínguez-Gil, A. 1989: Pharmacokinetics of rectal ketamine in children. British Journal of Anaesthesia 63(6): 671-674